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RESUMO 
O desenvolvimento e disseminação de tumores sólidos dependem da formação de 
uma rede vascular que permita o aporte de oxigénio e nutrientes, através de um 
processo denominado angiogénese. Este processo é regulado por diversos factores 
que compõem o microambiente tumoral tais como os níveis de oxigénio, acidificação e 
stress oxidativo. 
Sabe-se existir um nível elevado de espécies reactivas de oxigénio no microambiente 
tumoral que ao promover a desregulação de processos como a proliferação, a 
motilidade celular, a sobrevivência e angiogénese contribui para a iniciação, 
progressão e promoção tumoral. 
Estudos realizados no nosso laboratório demonstraram que a diminuição dos níveis 
celulares de H2O2, através da sobreexpressão de catalase em células de carcinoma 
mamário de ratinho 4T1, leva a uma diminuição do recrutamento de células 
endoteliais e invasão vascular, num modelo de xenotransplante em peixe-zebra. O 
presente estudo pretende identificar os mecanismos moleculares dependentes do 
H2O2 responsáveis pela regulação da angiogénese. Para isso analisamos alterações na 
expressão de genes relacionados com o processo angiogénico em populações de 
células 4T1 com sobrexpressão de catalase através de transfecção transiente com um 
plasmídeo que permite a co-expressão de catalase e da proteína reporter mCherry. 
A análise por PCR-array permitiu identificar vários alvos putativos do H2O2 incluindo 
efectores da via Notch e várias moléculas antiangiogénicas incluindo o inibidor de 
angiogénese específico de cérebro 1 (Bai1), a Trombospondina 1 (Thbs1) e o inibidor 
da metaloproteinase 3 (Timp3). 
Foi observado por hibridação in situ que as células 4T1 expressam os ligandos Dll4 e 
Jagged1, o receptor Notch3 e o efector Hes1 mas a sua expressão parece ser 
independente da sobrexpressão de catálase. 
Contrariamente aos componentes da via Notch, a expressão das proteínas Thbs1 e o 
Timp3 mostraram ser regulados pela sobreexpressão de catalase de uma forma não-
autónoma e de uma forma autónoma, respectivamente. A baixa expressão de HIF-1α 
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nas condições experimentais deste trabalho indica que a regulação destas proteínas é 
independente deste factor de transcrição chave na regulação de factores reguladores 
da angiogénese. Verificou-se também que os níveis de expressão da proteína Bai1 nas 
células 4T1 são demasiado baixos impossibilitando os estudos subsequentes.  
Os resultados obtidos neste trabalho mostraram que o nível de H2O2 nas células 
tumorais é capaz de regular a angiogénese através da modelação da expressão de 
moléculas anti-angiogénicas, de uma forma independente de HIF-1α.  
Para além da regulação autónoma da expressão de proteínas pelo H2O2, efeito já 
observado anteriormente por outros autores, este trabalho revela que a alteração dos 
níveis de H2O2 numa subpopulação de células tumorais é capaz de condicionar a 
resposta angiogénica global através de um mecanismo não-autónomo. Assim o 
conhecimento dos mecanismos moleculares dependentes de H2O2 torna-se essencial 
para o desenvolvimento de terapias mais eficazes contra o cancro.  
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ABSTRACT 
The development and dissemination of solid tumors depends upon the formation of a 
vascular network to supply oxygen and nutrients, through a process called 
angiogenesis. This process is regulated by several factors which are inherent to tumor 
microenvironment such as low oxygen levels, acidification and oxidative stress. 
A high level of Reactive Oxygen Species is known to exist in tumor microenvironment 
which helps the dysregulation of processes such as proliferation, cell motility, survival 
and angiogenesis contributing to tumor initiation, progression and promotion.  
Previous studies in our lab have demonstrated that lowering the cellular levels of H2O2 
through overexpression of catalase in 4T1 mouse breast tumor cells, leads to a 
decrease in endothelial cell recruitment and tumor vessel invasion in a Zebrafish 
xenotransplant model. 
The present study aims to identify H2O2 dependent molecular mechanisms responsible 
for angiogenesis regulation. We analyzed alterations in angiogenesis related gene 
expression in catalase overexpressing populations of the 4T1 cell line by transient 
transfection with a plasmid which allows co-expression of catalase and the mCherry 
reporter protein. 
Through PCR-array analysis several putative H2O2 targets were identified including 
Notch pathway effectors and several antiagiogenic molecules including Brain-specific 
angiogenesis inhibitor 1 (Bai1), Thrombospondin 1 (Thbs1) and Tissue inhibitor of 
metalloproteinase 3 (Timp3). 
Using in situ hybridization, we found that 4T1 tumor cells express the ligands Dll4 and 
Jagged1, the receptor Notch3 and effector Hes1 of the Notch pathway but their 
expression seems to be independent of catalase overexpression. 
Unlike the Notch pathway components, the expression of Thbs1 and Timp3 were 
found to be regulated by catalase overexpression in a non-autonomous and an 
autonomous mode, respectively. The low expression of HIF-1α in the experimental 
conditions used in this work indicates that the regulation of these proteins is 
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independent from this key transcription factor in angiogenesis regulation. We found 
that Bai1 expression levels in 4T1 cells are too low to allow for subsequent studies.  
The results obtained in this work have shown that the level of H2O2 in tumor cells is 
able to regulate angiogenesis in tumor cells through modulation of antiangiogenic 
molecules, in an HIF-1α independent manner.  
Aside from autonomous regulation of protein expression by H2O2, previously described 
by several authors, this work shows that altering H2O2 levels in a subpopulation of 
tumor cells is enough to condition the overall angiogenic response through a non-
autonomous mechanism. Thus, the understanding of H2O2 dependent molecular 
mechanisms is essential for developing more efficient antitumor therapies.      
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OBJECTIVES 
 
Previous results obtained in our laboratory (Rodrigues, G., Ms thesis, 2011) using the 
Zebrafish xenotransplantation model (Nicoli and Presta 2007) have shown that a 
decrease of H2O2  levels in tumor cells, due to transient catalase overexpression, 
impaired  endothelial cell recruitment, vascular invasion and branching in vivo. These 
results raised the following questions:  
 What are the angiogenic factors modulated by H2O2 in tumor cells? 
 How is a small population of cells overexpressing catalase able to regulate 
tumor angiogenesis?  
Therefore, the objectives of the present work are: 
 Production of an expression vector for catalase that allowed the identification 
of the transfected tumor cells. 
 Identification of angiogenic factors regulated by H2O2 in tumor cells. 
 To understand whether the regulation of protein expression by H2O2 is cell-
autonomous or non-autonomous. 
Another goal of this work is to produce a Zebrafish transgenic line that allows the 
study of the role of H2O2 levels in endothelial cells during the angiogenic process. 
For that the specific aims are: 
 Production of vectors for the inducible expression of catalase under the 
regulation of an endothelial cell specific promoter (Flk1).  
 Injection of the vectors in one cell stage zebrafish embryos for transgenic 
production. 
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INTRODUCTION 
 
THE ROLE OF REACTIVE OXYGEN SPECIES (ROS) IN CANCER 
Cancer remains one of the most prevalent, deadliest and costly health issues in the 
world despite enormous efforts and significant achievements in cancer prevention, 
diagnosis, treatment and basic research. 
Cancer statistics show that both the number of cases and mortality rate have been 
decreasing in the past few years in the United States of America (Siegel, Naishadham 
et al. 2012) but continue to increase worldwide and especially in developing countries 
(Jemal, Bray et al. 2011).  
 
TUMOR MICROENVIRONMENT 
Tumors are complex, heterogenic and dynamic structures consisting of three main 
components: tumor cells, tumor-associated cells and the extracellular matrix. Together 
they create an abnormal, interactive and evolving setting known as tumor 
microenvironment. 
Malignant cells are associated with characteristics such as sustained proliferation, 
promotion of inflammation, genomic instability, resistance to cell death, altered 
metabolism, ability to evade growth suppressors and immune defenses, angiogenic 
potential and increased motility and migration leading to metastatic ability, known as 
the hallmarks of cancer (Hanahan and Weinberg 2011). 
Tumor cells have various genetic modifications which include single mutations, 
amplification, loss or rearrangement of large regions of the genome leading to 
dominant gain of function and recessive loss of function in genes defined as oncogenes 
and tumor-suppressor genes, respectively (Sadikovic, B. et al 2008). 
Cancers are thought to result from distinct subclones that are selected according to 
best adapted phenotypes from genetically and epigenetically diverse backgrounds. 
This heterogeneity exists not only in tumor cells but also in other components of the 
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tumor microenvironment resulting in a variability in tumor architecture with important 
implications for tumor development, diagnosis and treatment (Almendro, Marusyk et 
al. 2013).  
Tumor-associated cells are cells which surround and interact with tumor cells 
contributing to tumor growth and dissemination. These include fibroblasts, immune 
cells, endothelial cells and other vasculature associated cells such as pericytes. .    
Stromal cells contained in the tumor microenvironment are biologically active, 
adopting a myofibroblastic phenotype and contributing to extracellular matrix 
remodeling, cell proliferation and migration and angiogenesis induction by secreting 
tumor promoting factors such as proteinases. Because of the stroma-tumor cells 
interdependence, stromal cells can be used for cancer prognosis and are a potential 
therapeutic target (Franco, Shaw et al. 2010).  
Vasculature cells present in the tumor microenvironment also behave abnormally 
creating a vascular network which while supplying nutrients and oxygen is also thought 
to promote tumor cell dissemination due to the aberrant permeability of tumor-
associated vessels (Garcia-Roman and Zentella-Dehesa 2013). 
Immune cells exist in high amounts in the tumor microenvironment and yet conversely 
do not eliminate tumor cells. Macrophages are the most abundant immune cell type 
found in tumors although tumor associated macrophages (TAMs) differentiate to the 
M2 type which are the main source of growth factors and cytokines (TGF-β1, PDGF, 
bFGF, TGF-α,  TNF-α and IL-1) that  promote angiogenesis, remodeling and  tissue 
repair instead of M1 type which is associated with antitumor activity. Similarly, other 
immune cells help create an inflammatory and prooxidant microenvironment often 
likened to a perpetual wound (Dvorak 1986) (Coussens and Werb 2002) (Feng, 
Santoriello et al. 2010). 
Besides cellular components, the tumor microenvironment is also constituted of 
several molecules that are dynamically regulated and play a crucial role in tumor 
maintenance and progression. The extracellular matrix (ECM) components are one of 
such examples. ECM is constituted by several proteins, such as collagen, fibronectin 
and laminin that are the basic components of basal membranes and function as a 
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substrate for cell adhesion and migration. Dysregulation of ECM homeostasis by the 
over expression of proteins responsible for the degradation and remodeling of ECM 
such as matrix metalloproteinases (MMPs), is a crucial event in cancer progression (Lu, 
Weaver et al. 2012). ECM sequesters proteases, cytokines, proteoglycans and growth 
factors which are inactive while imbedded in the matrix structure but can promote 
tumorigenesis upon matrix degradation.  
Hypoxia, acidosis and oxidative stress are also part of the tumor microenvironment 
and are a consequence of tumor cell metabolism deregulation.  
Tumor hypoxia has long been known to be an important feature of solid tumors and is 
attributed to a disorganized and inefficient vasculature that leads to hypoxic areas and 
fluctuations in O2 levels (Bertout, Patel et al. 2008). Key factors in sensing and 
responding to hypoxia are the transcription factors hypoxia inducible factors (HIFs, 
including HIF1, HIF2 and HIF3) which are controlled by oxygen amount and oxidative 
state of cells. They are relevant to the expression of hundreds of genes involved in 
processes responsible for cell survival in low oxygen conditions, such as cell 
metabolism, angiogenesis, proliferation, motility and survival. HIF levels are found to 
be altered in several tumor types and relate to tumor angiogenesis, metastization and 
prognostic (Bertout, Patel et al. 2008, Keith, Johnson et al. 2012).    
Acidosis in the tumor microenvironment (pH 5,6 to 6,8) is a characteristic of tumors 
while tumor cells maintain their intracellular pH neutral or alkaline (7.2 to 7.5) (Chiche, 
Brahimi-Horn et al. 2010). This acidification is generally attributed to the metabolic 
shift from oxidative phosphorylation to other metabolic pathways such as glycolysis 
and glutaminolysis as well as poor blood perfusion resulting in production of metabolic 
acids, such as lactic acid and their inefficient removal. Metabolic changes are driven by 
oncogenes as well as hypoxia and in turn acidosis promotes matrix degradation, death 
of surrounding normal cells and inhibits immune response to tumor cells (Gatenby, 
Gawlinski et al. 2006) 
Together with hypoxia and acidosis, tumors have long been described to have higher 
oxidation levels than normal tissues due to accumulation of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS). In cancer cells, the higher amounts of ROS 
promote changes that drive the tumorigenic process such as mutagenesis and 
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dysregulation of signaling pathways. However, due to an increase in the antioxidant 
response, cancer cells are able to adapt and overcome oxidative stress. Even though 
the thresholds for normal and cancer cells can differ considerably, all cells reach a 
point at which the ROS concentration is too high to allow cellular processes to 
continue and in these cases cells enter senescence or cell death occurs (Lopez-Lazaro 
2007).     
 
Fig.1: The different effects of ROS on cellular processes and their dependence on 
concentration (Cairns, Harris et al. 2011) 
 
BIOLOGICAL FUNCTION OF ROS  
Reactive oxygen species (ROS) is the term used to refer to a variety of reactive 
molecules containing oxygen. 
There are two types of ROS: radicals, which contain one or more unpaired electron(s) 
in their outer molecular orbitals such as superoxide (O2-) nitric oxide (NO-), hydroxyl 
ion (OH) and peroxyl radicals (RO2-) and non-radical ROS, which do not have unpaired 
electron(s) but are chemically reactive and can be converted to radicals. These include, 
ozone (O3), peroxynitrate (NO4), and hydrogen peroxide (H2O2). 
The formation of ROS in cells is mostly a natural consequence of the respiratory 
process. In the electron transport chain (ETC), during energy transduction, some 
electrons “leak” mostly at complexes I and III and react prematurely with molecules of 
O2 forming superoxide anion. These highly reactive molecules react with other 
molecules to form the OH- and H2O2 reactive species, among others (Drose and Brandt 
2012). Aside from the mitochondrial ETC, ROS are produced by NADPH oxidases (Nox), 
the enzymes lipoxygenase and cyclooxygenase, xanthine oxidases, peroxidases and 
other hemoproteins, often in response to extracellular stimulus such as cytokines and 
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growth factors. ROS production can also result from external factors such as radiation 
or pollution.   
The effects of ROS depend upon their concentration within cells. In normal cells, where 
a low steady-state concentration is maintained, many ROS act as signaling molecules 
interacting with cell components and contributing to fundamental processes such as 
cell proliferation and survival. 
To avoid potential damage caused by oxidants, cells have an array of antioxidant 
molecules such as vitamins but the main line of defense is a system of antioxidant 
enzymes. 
These include superoxide dismutases (SOD), such as MnSOD in the mitochondria and 
Cu/Zn SODs in the nucleus and cytosol that specifically dismutate the highly reactive 
O2- into H2O2. Thioredoxins, peroxidases such as glutathione peroxidase and catalase 
reduce hydrogen peroxide to water. 
The amount and localization of these enzymes is tightly controlled not only to avoid 
oxidative damage but also modulate signaling by ROS (Melo, Monteiro et al. 2011). 
 
Fig. 2: Sites of cellular reactive oxygen species (ROS) generation (red) and major ROS-
scavenging enzyme (yellow and green) (Trachootham, Alexandre et al. 2009) 
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The main regulator of cell response to oxidative stress is the Keap1-Nrf2 pathway 
where Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that 
binds to the antioxidant response element (ARE) present in the regulatory regions of 
genes involved in redox homeostasis such as NAD(P)H quinone reductase (NQO1), 
glutathione S-transferase (GST), glutathione peroxidase, glutathione reductase and 
ferritin.  Keap1 (Kelch ECH associating protein 1), is a cysteine-rich protein which is 
sensitive to redox environment and binds to Nrf2 leading to its proteossomal 
degradation. Oxidation of Keap1 is thought to change its conformation making it 
unable to bind to newly synthesized Nrf2 (Thimmulappa, Mai et al. 2002, Kansanen, 
Kuosmanen et al. 2013).  
 
THE KEY ROLE OF H2O2 
While more reactive species like OH- can react indiscriminately and have short half 
lives, hydrogen peroxide presents characteristics that allow it to act as signaling 
molecule in a wide variety of pathways. 
H2O2 is a weak oxidant with a relatively long cellular half-life (~1 ms, steady-state levels 
~10–7 M) that reacts slowly with free metals, free glutathione and methionine residues 
but in contrast is very reactive with thiol groups of cysteine residues. The effect of 
H2O2 on its targets depends upon concentration, with possible reversible and 
irreversible reaction products. (D'Autreaux and Toledano 2007). 
 
Fig. 3:  Cysteine biochemistry allows for redox-dependent signalling by hydrogen peroxide 
(H2O2). An initial reaction with a thiolate yields sulfenic acid which can then further 
react originating reversible and irreversible products depending on H2O2 concentration 
(Finkel 2011) 
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H2O2 reacts directly with cysteine residues having pKa lower than 6 promoting the 
formation of disulfide bonds. These reactions can alter protein structure, affecting 
protein interactions and activities and happen in a temporal and sequence-specific 
manner.  
 
Fig. 4: Protein oxidation by ROS affects protein functions through multiple 
mechanisms. Oxidation levels can modulate transcription factors altering protein 
expression, can cause post-translational modifications that alter protein structure and 
reactivity, including modulating the activity of modifying enzymes such as 
phosphatases and can alter protein stability and subsequent degradation 
(Trachootham, Alexandre et al. 2009) 
Although, unlike other ROS, H2O2 can diffuse through membranes and this diffusion 
might be modulated by changes in membrane permeability or by transport through 
aquaporins (D'Autreaux and Toledano 2007). The presence of H2O2 producing enzymes 
such as NADPH oxidases and H2O2 elimination enzymes such as catalase in specific 
cellular locations helps to modulate H2O2 concentrations and hence its reactivity within 
the cell (Finkel 2011). 
REDOX REGULATION IN CANCER 
ROS are known for having deleterious effects on cell components and increasing 
toxicity with higher concentrations, hence the necessity of antioxidant mechanisms 
within the cells. 
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“Oxidative stress’ is an expression used to describe various deleterious processes 
resulting from an imbalance due to excessive formation of ROS and/or RNS and limited 
antioxidant defenses. Because of its widespread effects, oxidative stress is associated 
with many diseases such as cancer, Alzheimer’s, diabetes and cardiovascular injuries 
(Waris G. and Ahsan H. 2006). 
An increase in ROS in some tumor cells has been known to exist for a long time 
(Szatrowski and Nathan 1991) and its relation to tumor aggressiveness has been 
established in several tumors of which prostate cancer (Kumar, Koul et al. 2008), 
hepatocellular carcinoma (Suzuki, Imai et al. 2013), non-small cell lung carcinoma 
(Ceccarelli, Delfino et al. 2008) and pancreatic cancer (Kodydkova, Vavrova et al. 2013) 
are examples. However, an increase in markers of oxidative stress has been linked to 
better prognosis (Evans, Dizdaroglu et al. 2004, Karihtala, Kauppila et al. 2011) 
confirming that the relation between ROS levels and cancer is not yet understood. 
Increasing ROS levels extracellularly or by genetic manipulation alters cell behavior as 
demonstrated by cell exposure to H2O2 sources increasing proliferation in epithelial 
cells (Sigaud, Evelson et al. 2005) and increasing mitochondrial ROS production via 
mutagenesis leading to metastatic behavior (Ishikawa, Takenaga et al. 2008) 
Studies in vitro and in vivo have demonstrated that altering the levels of different ROS 
by overexpression of antioxidant enzymes, such as SODs and catalase or addition of 
reducing agents, also show effects in cancer development. Overexpression of copper 
zinc superoxide dismutase (CuZnSOD) (Zhang, Zhao et al. 2002) manganese SOD 
(MnSOD) and copper- zinc SOD (CuZnSOD)(Weydert, Waugh et al. 2006) have 
suppressive or delaying effects on tumor growth. ROS have also an important role in 
tumor microenvironment components such as endothelial and myeloid cells in which 
catalase overexpression reduces tumor aggressiveness in vitro (Glorieux, Dejeans et al. 
2011) and in vivo (Goh, Enns et al. 2011) 
 
In carcinogenesis, ROS have a decisive role due to a plethora of effects involved in 
tumor initiation, promotion and progression. 
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Genetic and epigenetic alterations 
ROS, in particular hydroxyl radicals derived from H2O2 via Fenton reaction, have a role 
in tumor initiation by inducing direct damage to DNA, such as 8-hydroxy-2-
deoxyguanosine (8-oxo-dG), the most common oxidation product of guanine which 
can give rise to G-to-T transversion mutations in key genes known to be involved in the 
development of cancer. An increase in 8-oxo-dG lesions in cellular DNA favors higher 
rates of mutation, leading over time to an increase in the risk for cancer (Ziech, Franco 
et al. 2011).  
Aside from direct DNA damage, ROS have been implicated in gene regulation through 
epigenetic changes such a hypermethylation of promoter regions of tumor-suppressor 
genes like RUNX3 and CDX1 in colorectal cancer cells (Kang, Zhang et al. 2012, Zhang, 
Kang et al. 2013) and E-cadherin in hepatocellular carcinoma (Lim, Gu et al. 2008). In 
hepatocellular carcinoma, a tumor type strongly associated with oxidative stress, the 
expression of catalase is downregulated by prolonged exposure to ROS via promoter 
methylation, allegedly leading to a more aggressive phenotype (Min, Lim et al. 2010).  
Another type of direct damage is chromosome instability which has been linked to 
oxidative stress, for instance in cells lacking SOD (Samper, Nicholls et al. 2003), and is a 
common feature of many cancers (Negrini, Gorgoulis et al. 2010). 
 
Transcription factor expression and activity modulation 
Several transcription factors involved in tumor-promoting gene expression are 
modulated by ROS.  
Particular key transcription factors in tumors are the HIF protein family, which activate 
a large number of genes that are involved in cell survival processes in low oxygen 
conditions. HIF 1 is a heterodimer composed of HIF 1α and HIF 1β. HIF 1β is 
constitutively expressed while HIF 1α amount is tightly regulated through both protein 
synthesis and degradation. 
HIF-1 synthesis is upregulated by growth factors in paracrine and autocrine fashions in 
an O2 independent manner. Pathways involved in HIF transcription activation include 
mitogen-activated protein kinase (MAPK) and phosphatidylinositide 3-kinases (PI3K) 
and these can be disrupted in cancer cells through loss or gain-of-function of the 
proteins involved. 
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The degradation of HIF-1α is oxygen dependent, since its ubiquitination depends upon 
reactions where O2 is a limiting reagent. In normoxia, the enzyme PHD (prolyl 
hydroxylase domain protein) 2 hydroxylates residues Proline 402 and Proline 562 in a 
reaction that converts 2-oxoglutarate to succinate. These PHDs require several 
cofactors, including 2-oxoglutarate, iron and ascorbate in addition to oxygen which 
supplies the oxygen atom for the hydroxyl group (Kaelin 2002).This hydroxylation allows 
the von Hippel Lindau (VHL) tumor suppressor protein to bind to HIF-1α followed by binding of 
ubiquitin3 which tags the protein for proteossomal degradation.  
The level of ROS, specifically H2O2, within the cell can influence HIF-α synthesis through 
its modulation of the MAPK and PI3K pathways and can arguably also affect its 
degradation mechanism since hydrogen peroxide reacts with 2-oxoglutarate, Fe2+ and 
ascorbate and can thus limit Proline hydroxylation by PHDs (Qutub and Popel 2008).  
 
Fig. 5: ROS regulation of intracellular HIF 1α. Intracellular ROS modulate HIF 1α 
transcription via NF-kB and PI3K pathway activation as well as degradation by 
decreasing availability of PHD co-factors. (Zhou, Yan et al. 2013) 
 
Also redox regulated is NFκB due to phosphorylation of the inhibitor I-κB which is 
mediated by oxidation. In addition the binding of the p50 subunit of NFkB to the DNA 
depends on reduction of an essential cysteine group (Katsuyuki, Kohzo et al. 1994) and 
is tightly regulated by H2O2 (Oliveira-Marques et al, 2009). NFκB activation can be 
triggered by oxidants in the absence of any physiological stimulus and is inhibited by a 
broad range chemically unrelated antioxidants (Flohe, Brigelius-Flohe et al. 1997). The 
Introduction 
 
   12 
transcription factor AP-1 is also redox regulated since DNA biding depends on the 
reduction of cysteines in the subunits c-Jun and c-Fos (Abate, Patel et al. 1990). 
 
Regulation of signal transduction 
ROS are involved in several signal transduction cascades responsible for 
determining cellular proliferation or survival including the extracellular signal-
regulated kinase (ERK) MAPK pathway, and the PI3K/Akt pathway. ROS induced 
dysregulation of these pathways may reduce cell dependence on growth factors. 
The role of ROS in modulating signaling of these kinase pathways is largely attributed 
to reversible oxidative inactivation of protein tyrosine phosphatases (PTP), which 
inhibit signaling by dephosphorylating pathway components. 
One of the first studies that established a direct connection between ROS and 
carcinogenesis is related to TGF-β signaling. TGF-β activation induces an increase in 
intracellular ROS in a process associated with the phosphorylation of Smad2, p38α and 
ERK1/2 (Rhyu, Yang et al. 2005). This molecular mechanism is required for tumor 
invasion and metastasis (McEarchern, Kobie et al. 2001) 
In addition to these direct roles in intracellular signaling, the building up of local 
H2O2 gradients by modulation of antioxidant enzymes (Woo, Yim et al. 2010) affects 
other processes important to cancer promoting characteristics such as cell-to-cell 
adhesion (Goitre, Pergolizzi et al. 2012) and cytoskeletal reorganization (Jin, Lin et al. 
2012) (Tochhawng, Deng et al. 2013). 
The role of ROS in cancer and endothelial cells is determinant for the process of 
angiogenesis which is essential to tumor growth. Tumors produce many pro-
angiogenic factors, such as vascular endothelial growth factor (VEGF), MMPs, 
angiopoietin-1, fibroblast growth factor (FGF), interleukin-8 (IL-8), platelet-derived 
growth factor (PDGF) and TGF-β. ROS are involved in the regulation of some of these 
factors, in particular VEGF, which is highly upregulated in most human cancers 
(Ferrara, Hillan et al. 2004).  
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ROS modulation of the tumor microenvironment 
ROS are increased not only in tumor cells but also accumulate in tumor 
microenvironment since inflammatory response at the tumor site creates large 
amounts of ROS that are produced by activated neutrophils and macrophages.  
ROS play an important part in the tumor microenvironment pro-inflammatory and pro-
angiogenic features through pathways such as TGF-β signaling. TGF-β is a tumor 
environment modulator, due to the regulation of immune cell and fibroblast 
infiltration (Yang 2010).  ROS also leads to the activation of MMPs via oxidation (Weiss, 
Peppin et al. 1985)  that in turn increase mitochondrial ROS production by expression 
of an alternative splice product of Rac1 (Radisky, Levy et al. 2005). Another way in 
which stromal cells enable cancer cells oxidative stress is by supplying them with 
antioxidants as reportedly happens with bone-marrow-derived stromal cells which 
provide cysteine that enables leukaemia cells to resist oxidative stress (DeBerardinis 
2012).  
 
H2O2 has also been described as a possible chemoattractant for immune cells in wound 
repair (Niethammer, Grabher et al. 2009) and activator of macrophages (Owegi, Egot-
Lemaire et al. 2010) with eventual implications for tumor microenvironment (Hurd, 
DeGennaro et al. 2012) .  
Many proteins with relevance in cancer development can be altered through 
posttranslational modifications resulting from oxidative stress (Jorgenson, Zhong et al. 
2013) 
The plasmin protease is an example of redox regulation. It is activated by cleavage of 
its zymogen plasminogen and has a tumorigenic effect mainly through ECM 
degradation. However, plasmin is a precursor of angiostatin, an endogenous 
angiogenesis inhibitor. The cleavage of the N-terminal fragment of plasmin, which 
originates angiostatin, happens after reduction of 2 disulfide bonds and consequent 
conformational change (Cook and Hogg 2013). 
ROS play a determinant part in cancer treatment as both radiation and several 
chemotherapy drugs increase oxidative stress since the high ROS content in cancer 
cells renders them more susceptible to oxidative stress–induced cell death (Fang, 
Nakamura et al. 2007). More recently however, the important role of therapy resistant 
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cancer stem cells (CSCs) in tumor relapse (Malik and Nie 2012) that present lower 
levels of ROS presumably due to more efficient antioxidant systems, has become the 
focus of cancer therapy research, highlighting once again the importance of redox 
regulation in cancer (Diehn, Cho et al. 2009).    
 
TUMOR ANGIOGENESIS 
Role of vasculature in cancer development  
An adequate supply of oxygen and nutrients is critical for homeostasis of virtually all 
cells and tissues. The delivery of oxygen and nutrients, as well as the elimination of 
metabolic waste and carbon dioxide, occur through the vascular system, which is 
expanded by the processes of vasculogenesis and angiogenesis. 
Tumors originate from small cellular masses with unchecked growth. As cells multiply 
both the oxygen and nutrients supplies needed for cell survival and proliferation 
become limiting leading to an equilibrium between cell proliferation and cell death. To 
grow beyond 1-2 mm in diameter and become a tumor this mass needs independent 
blood supply. This happens when cells acquire the capacity to induce blood vessel 
growth, in a process called tumor angiogenesis (Folkman 1974). 
The existence of a tumor vasculature also helps cancer cells to enter the blood stream 
and spread to new locations leading to metastasis. In most cases the vascularization 
level of a solid tumor is thought to be an excellent indicator of its metastatic potential. 
Formation of new blood vessels continues throughout tumor development being 
stimulated by pro-angiogenic factors especially in hypoxic tumor areas. 
Another mechanism responsible for new vessel formation is called vasculogenesis. 
Vasculogenesis is the de novo formation of blood vessels through the differentiation of 
endothelial cell progenitors, the angioblasts (Risau and Flamme 1995). Although 
primarily important during development, post-natal vasculogenesis can also occur in 
the adult with bone marrow-derived endothelial progenitor cells being recruited to 
locations that present vascular stress, such as tumors. 
Other mechanisms of vessel remodeling might also occur in tumors such as 
intussusception and vascular co-option (Carmeliet and Jain 2011), although these are 
less frequently described. 
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However, the predominant and better understood mechanism for new tumor 
vasculature formation is angiogenesis in which new blood vessels directed to the 
tumor mass sprout from pre-existing normal ones. 
 
Mature vasculature consists of a system of tubes including arteries, arterioles, 
capillaries, venules and veins that promote the circulation of oxygenated blood 
between the heart, lungs and tissues (Herbert and Stainier 2011). The vessels in this 
network are formed by a monolayer of quiescent endothelial cells, interconnected by 
junctional molecules such as VE-cadherins and surrounded by vascular smooth muscle 
cells (vSMCs) or pericytes. vSMCs and pericytes are mesenchymal cell types with 
finger-like projections that wrap around vessel tubes. Their function is to stabilize 
blood vessels, contribute to the synthesis of vascular basement membrane that helps 
vessels withstand the pressure of blood flow and provide paracrine signaling essential 
to endothelium quiescence. 
 
Molecular mechanism for vessel formation 
Normal angiogenesis is a complex, highly regulated process (Herbert and Stainier 
2011), involving a large number of pro-angiogenic and anti-angiogenic factors, 
consisting of the following main steps: 
1. Angiogenic signaling and vessel destabilization 
Quiescent endothelial cells receive angiogenic signals, such as VEGF, ANG-2, FGFs or 
chemokynes released by hypoxic, inflammatory or tumor cells, which activate 
endothelial cells inducing cell migration and proliferation.  
The processes of endothelial cell migration and proliferation can only happen after 
basement membrane degradation and pericyte detachment from the capillary wall. 
This occurs by the action of extracellular proteinases known as matrix 
metalloproteinases (MMPs).  
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2. Tip cell selection and branching 
The destabilization allows endothelial cell junctions to loosen, the vessel to dilate and 
the formation of a branch point. Proteinases degrade the matrix and remodel it to 
allow for endothelial cells migration and, at the same time, release angiogenic factors 
that are attached to the ECM, increasing the angiogenic stimulus. Integrins expressed 
by endothelial cells interact with specific components of the ECM, helping a directional 
migration.  
Because not all cells can migrate equally, one cell is selected to lead the new vessel, 
named tip cell, while other cells, named stalk cells, follow and form the surface of the 
new vessel. The selection of the tip cell involves the notch signaling pathway, where 
the expression of notch ligands such as Delta like 4 and Jagged 1 in tip cells is detected 
by the notch receptors of neighboring cells that, as a result, repress production of 
molecules such as the VEGF receptor, effectively stopping them from becoming tip 
cells (Herbert and Stainier 2011). 
Tip cells present specific characteristic such as high mobility, filopodia, increased 
sensitivity to angiogenic signals and high expression of VEGF receptor, which allow 
them to lead the branching of the new vessel in response to extracellular signaling.   
3. Anastomosis and vessel stabilization 
After endothelial cell proliferation in a given direction, the cells reorganize in order to 
form a tube structure with a central lumen with ANG-1 produced by the endothelial 
cells leading to vessel stabilization. New vessels then connect to reestablish the 
network and blood flow in a process known as anastomosis. 
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Fig. 6: The stages of angiogenesis: schematic representation of the steps in the 
angiogenic process as well as some of the main regulating factors involved (Clapp, 
Thebault et al. 2009). 
 
In tumors, the angiogenic process is dependent on the activation of oncogenes, such 
as ras and c-myb, which upregulate pro-angiogenic factors or downregulate anti-
angiogenic factors (Rak, Yu et al. 2000) . It is also dependent on signalling from 
components of the tumor microenvironment such as  macrophages, fibroblasts and 
the extracellular matrix and it can be modulated by proteins in growth factors 
transduction pathways such as MAPK (Rousseau, Houle et al. 1997).  
Role of H2O2 in angiogenesis 
 Reactive oxygen species, in particular superoxide and hydrogen peroxide, have long 
been known to be involved in cell proliferation and migration of different cell types 
since exogenous ROS addition in low concentrations stimulated migration and 
proliferation but did not induce cell death (Burdon 1995). 
Additionally, studies in which ROS concentrations were lowered, either by blocking 
their production via the ETC or NADP(H) oxidases or promoting their degradation via 
antioxidant enzyme overexpression, have shown a decrease in cell migration, 
proliferation and adhesion due to disruption in signal transduction cascades (Brown, 
Miller et al. 1999), (Glorieux, Dejeans et al. 2011), (Goh, Enns et al. 2011). 
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An example is the vascular endothelial growth factor (VEGF) signaling pathway which 
controls multiple aspects of endothelial behavior such as endothelial differentiation, 
migration, proliferation, survival, and permeability (Ferrara, Gerber et al. 2003). 
The best characterized ROS-modulated pathway involves the VEGF receptor 2 
(VEGFR2, also called flt1 or KDR) signaling in endothelial cells. Although VEGF-A 
isoforms have a higher affinity for binding to VEGFR1, the tyrosine kinase activity of 
VEGFR2 is the main mediator of VEGF-A signaling during sprouting angiogenesis. This 
happens due to localized ROS induced inactivation of phosphatases, potentiating 
VEGFR2 phosphorylation. 
Upon VEGF binding to VEGFR2, the small GTPase Rac1 is activated and translocates to 
the plasma membrane where it binds to the Nox2 subunit of NAD(P)H oxidase (Kao, 
Gianni et al. 2008), stimulating superoxide production and release into the 
extracellular medium. There this radical is dismutated to hydrogen peroxide which 
enters the cell through membrane diffusion or aquaporins situated near the VEGFR. 
The local increase in H2O2 leads to reversible oxidation and inactivation of protein 
tyrosine phosphatases (PTPs). While PTPs are inactive, VEGFR2 autophosphorylation is 
enhanced as well as downstream cSrc, FAK, PI3K and ERK signaling for which ROS are 
required, ultimately resulting in a stronger response from endothelial cells (Abid, 
Spokes et al. 2007). 
 
Fig. 7: ROS modulation of endothelial cell response to VEGF via NAD(P)H oxidase 
activation. VEGF binding to VEGFR2 activates Rac1 which binds to membrane bound 
NAD(P)H oxidases increasing ROS production. Reversible oxidative inactivation of 
Protein Tyrosine Phosphatases temporarily results in increased VEGFR2 
autophosphorylation and VEGF signal reinforcement (Ushio-Fukai 2006).  
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Similar mechanisms exist to modulate signaling of other proangiogenic factors such as 
epidermal growth factor (EGF) (Truong and Carroll 2012), platelet-derived growth 
factor (PDGF) (Kang, Rhee et al. 2005) and angiopoietin1 (Harfouche, Malak et al. 
2005). 
ROS are also involved in the modulation of previously described pathways such as 
MAPK, PI3K, TGF-β (Wu 2006, Son, Cheong et al. 2011) and transcription factor 
regulation such as AP-1, NF-κB and HIF1-α. These regulate other factors relevant in 
angiogenesis such as MMPs, MMPs natural inhibitors TIMPs and Notch pathway 
signaling (Zhou, Yan et al. 2013). 
Despite the well-established relevance of ROS in cancer cells, endothelial cells and the 
tumor microenvironment, little is known about their role in interactions between 
different cell types. Specifically, the role of hydrogen peroxide as signaling molecule in 
a direct or indirect fashion is still incompletely understood. 
 
THE ZEBRAFISH MODEL  
Our study focuses on the effect of lowering H2O2 levels in cancer cells and endothelial 
cells on tumor angiogenesis. 
The Zebrafish (Danio rerio) xenograft model was used to evaluate the effect of 
lowering H2O2 levels in cancer cells on the recruitment of endothelial cells. In further 
studies, we will study the effect of lowering H2O2 levels in endothelial cells on 
angiogenesis using transgenic Zebrafish. 
Zebrafish presents many advantages as a model organism for the study of diseases. Zebrafish 
husbandry is comparatively easy in relation to other organisms and they can be obtained in large 
quantities. The embryos transparency and ex-utero development allow for phenotypic studies 
using non-invasive methods and xenografts are simplified due to immunoprivilege in the early 
stages of development. The organism is amenable to genetic manipulation with many genetic 
tools such as transposons, morpholinos and a large number of transgenic lines already in 
existence. The study of angiogenesis also benefits from detailed knowledge of Zebrafish 
vasculature and development as well as the similarities to humans in the molecular processes of 
vasculogenesis and angiogenesis, with angiogenic sprouting being easily visualized in Zebrafish 
embryos (Liu and Leach 2011) (Nicoli and Presta 2007) 
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MATERIALS AND METHODS 
 
1.  CELL CULTURE  
All cell culture procedures were performed in a laminar flow hood (ClanLAF VFRS1206), 
using sterile disposable plasticware. 
The 4T1 mouse mammary carcinoma cell line was used throughout this work. Cells 
were cultured as monolayers in high glucose Dulbecco's Modified Eagle Medium 
(DMEM) supplemented 100 units/ml penicillin, 100 μg/ml streptomycin, L-Glutamine 2 
mM (referred to as DMEM unless otherwise specified) and 10% fetal bovine serum 
(FBS, inactivated at 56ºC for 20 minutes and filtered using a 25 µm filter) and 
maintained at 37°C in a humidified atmosphere containing 5% CO2.  
Cell passaging was done when cells reached approximately 80% confluence. Growth 
medium was removed and cells were washed twice with a 1x phosphate buffer saline 
(PBS) solution. A solution of trypsin 0,25% with 1 mM EDTA in 1xPBS was added so as 
to cover the monolayer and cells were incubated at 37ºC for a maximum of 3 minutes. 
Cells were then centrifuged at 169 g for 5 minutes and resuspended in growth media. 
The amount of cells seeded was determined after counting the cells in a 
hemocytometer. 
 
2.  TRANSFECTION OPTIMIZATION  
Transfection of 4T1 cells was attempted by electroporation as well as using the 
cationic-lipid transfection reagents Lipofectamine® 2000 (Invitrogen) and Fugene® 6 
(Promega). In order to estimate transfection efficiency the pCIC mCherry-NLS plasmid, 
containing the mCherry fluorescent protein, was used.  
2.1 Electroporation 
Cells were tripsinized at approximately 80% confluence, counted, resuspended in 400 
µl of the appropriate medium (see table), placed in a 0,4 cm cuvette and 
electroporated using the Gene Pulser Xcell (BioRad) with the following conditions: 
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Number of 
cells 
Medium Wave type Time 
(ms)  
Voltage 
(V) 
5x105 DMEM Exponential 15 156 
5x105 DMEM Square 15,5 158 
5x105 OptiMEM Exponential 15 156 
5x105 OptiMEM Square 17,4 158 
5x105 OptiMEM Square 20 278 
5x105 OptiMEM Exponential 53,4 197 
5x105 OptiMEM Exponential 40,5 298 
5x105 OptiMEM Exponential 6 1491 
1x105 OptiMEM Exponential 6 1499 
Table 1: Experimental conditions for electroporation of 4T1 cells. 
 
Cells were plated in 24 well plates containing cover slips in DMEM complemented with 
10% FBS and incubated at 37ºC, 5% CO2 for 14-18 hours. 
 
2.2 Lipid transfection reagents 
The reagents lipofectamine 2000® (Invitrogen) and FuGENE 6® (Promega) were tested. 
Cells were seeded in 96 or 24 well plates at different densities (see table 2 below) in 
DMEM complemented with 10% FBS but no antibiotics 16-20 hours before 
transfection. 
Different ratios of reagent:DNA were used (see table 2 below) and transfection was 
tested by diluting lipofectamine and DNA in the quantities below in 1:8 final cell 
culture volume of OptiMEM®  each in separate tubes in Opti-MEM media (Invitrogen) 
and let stand for 5 minutes as room temperate. The lipofectamine and DNA solutions 
were then gently mixed together and left at room temperature for 20 minutes to allow 
for formation of lipofectamine:DNA complexes and the mix was gently distributed over 
the cells. FuGENE 6 in the quantities specified below was mixed in 1:10 final cell 
culture volume of OptiMEM® and incubated for 5 minutes. Next the appropriate 
amount of DNA was added to this solution, mixed and incubated for 15 minutes. The 
mix was then gently added to the cell culture.  
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Cell density (cells/cm2) Lipofectamine:DNA 
(µl/µg)  
per ml cell culture 
Fugene:DNA 
(µl/µg) 
per ml cell culture 
 
1,5x105 
 
2,5:2,5 5:2,5 
5:2,5 7,5:2,5 
10:2,5 15:2,5 
 
2,5x105 
2,5:2,5 5:2,5 
5:2,5 7,5:2,5 
10:2,5 15:2,5 
 
5x105 
2,5:2,5 5:2,5 
5:2,5 7,5:2,5 
10:2,5 15:2,5 
Table 2: Experimental conditions for transfection of 4T1 cells with lipid reagents. 
 
Cells were incubated for a further 24 hours before transfection efficiency was 
determined. 
 
2.3 Transfection efficiency determination 
Preliminary tests were performed in 96 well plates and comparative transfection 
efficiency was done by measuring mCherry using a SpectraMax Gemini fluorometer.  
Conditions with best results were then tested in 24 well plates with cover slips and 
transfection efficiency was determined using fluorescence microscopy. Briefly, cells 
were washed with PBS, fixed in 4%PFA (paraformaldehyde) for 30 minutes and again 
washed with PBS. DAPI (4',6-diamidino-2-phenylindole) was added at 1 µg/ml, left for 
5 minutes and cells were again washed with PBS. Fixed cells were stored in PBS at 4ºC 
in the dark. 
The coverslips were mounted on a lamella with mowiol® (Sigma-Aldrich) and cells were 
observed using an Olympus BX60 microscope with 20x amplification. Random sections 
were photographed and number of transfected and total cells was counted using 4 
photographs for each condition (ImageJ software) and transfection efficiency 
calculated. 
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3.  CELL TRANSFECTION  
After optimization it was determined that the most efficient transfection method was 
using Lipofectamine® 2000 (Invitrogen) as described below.  
Cells were seeded at a density of 2,5x104/cm2 approximately 16 hours before 
transfection in DMEM complemented with 10% FBS but no antibiotics. Lipofectamine 
was diluted 1:50 and DNA was diluted to 20 µg/µl in separate tubes in Opti-MEM and 
let stand for 5 minutes as room temperate. The lipofectamine was gently mixed with 
the DNA in a 1 µl lipofectamine to 1 µg DNA proportion and left at room temperature 
for 20 minutes. This mix was then added to the cells in FBS and antibiotic free DMEM 
media as the process of transfection is inhibited by these additives. After 
approximately 7 hours the transfection media was replaced by DMEM containing 
penicillin and streptomycin and complemented with 10% FBS. Cells were maintained 
for 24 hours before subsequent experiments to allow for the expression of the 
proteins of interest.   
 
4.  NATIVE GEL CATALASE ACTIVITY ASSAY  
Activity of exogenous catalase was observed using a non-denaturing polyacrylamide 
gel to separate the native protein followed by coloring with potassium ferrocyanide 
and ferric chloride, which react only in the presence of peroxide to form the 
precipitate Prussian Blue (Weydert and Cullen 2010). 
 
4.1 Protein extraction 
HeLa cells were transfected as described above with control and catalase plasmid in 6-
well plates, with a transfection efficiency of 40-45%, and total protein was extracted at 
different time points after transfection: 8 hours, 16 hours and 24 hours. 
Cells were washed with PBS, scraped with the aid of a rubber policeman and 
centrifuged for 5 min at 200g, 4 °C. The supernatant was removed the cells 
resuspended 50 µl of 50 mM phosphate buffer (PB, pH 7.8).  Cells were sonicated on 
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ice 3 times for 2 minutes with 30 seconds intervals using a Sonorex TK52 sonicator. Cell 
pellets were stored at − 20 °C until assayed.  
 
4.2 Protein quantification 
The concentration of protein present in cellular extracts was determined using the 
standard Bradford protein assay. This assay is based on the shift observed in the 
absorption maximum of the Brilliant Blue G-250 dye upon its binding to protein as 
described by Bradford M. (Bradford 1976).  
A calibration curve was made using standard solutions of known concentration of 
Bovine Serum Albumin (BSA) between 0,1 µg/µl  and 1,25 µg/µl. In 96-well plates, 250 
µl of Bradford reagent (Sigma) were added to 5 µl of standards, samples or distilled 
water (blank) in triplicate and the mix was incubated in darkness for 30 minutes with 
gentle agitation. Absorbance at 595 nm was then read in a microplate reader (Tecan 
Sunrise). 
 
4.3 Protein separation by polyacrylamide native gel 
Native polyacrylamide gels consisting of an 8% separating gel topped by an 5% stacking 
gel were prepared in a protean apparatus (Biorad) with 1,5 mm spacers using the 
following quantities:  
Reagent Volume for 8% 
separating gel 
Volume for 5% 
stacking gel 
ddH2O 10,95 ml - 
Acyl-Bis 30% (wt/vol) 4,8 ml 1 ml 
Tris separating buffer pH 8.8 2,25 ml - 
Tris stacking buffer pH 6.8 - 2,4 ml 
Sucrose 40% (wt/vol) - 3,2 ml 
TEMED 9 μl 4 μl 
APS 10% (wt/vol) 68 μl 40 μl 
Table 3: Composition of native polyacrylamide gels for native gel catalase activity assay. 
The gel was first run in pre-electrophoresis buffer for 1 h, at 40 mA at 4 °C to remove 
gel components that may inactivate proteins. After this run, samples were loaded. For 
each sample a total of 20 µg was used, applied diluted 1:1 in sample loading. Positive 
controls of 100 mU, 1 U and 2 U bovine liver catalase were used. Samples were run in 
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the pre-electrophoresis buffer for 3 h at 40 mA at 4 °C. The pre-electrophoresis buffer 
was then replaced by electrophoresis buffer and the gel run in the same conditions for 
approximately another 3 hours, stopping 1 hour after the dye front reached the gel 
bottom. 
 
4.4 Gel staining 
The gel was washed in distilled water three times for 10 minutes each time and then 
incubated in a 0,003% H2O2 solution for 10 minutes. After rinsing twice with distilled 
water for 5 minutes, the two staining solutions of ferric chloride (2% (wt/vol)) and 
potassium ferricyanide (2% (wt/vol)) were added simultaneously. 
In the areas where H2O2 is present the following reaction occurs:   
2 K4FeC6N6 + H2O2 -----> 2 K3Fe(CN)6 + 2 KOH 
The resulting ferrocyanide then reacts with ferric chloride: 
4 FeCl3 + 3 K4Fe(CN)6 -----> Fe4[Fe(CN)6]3 + 12 KCl 
The resulting compound, known as Prussian Blue, forms a precipitate that covers the 
gel except in the areas where catalase activity has depleted H2O2, forming achromatic 
bands proportionate to catalase activity. After these bands have appeared, the stain 
was removed and the gel was rinsed several times with distilled water and left at room 
temperature for 18–24 h in distilled water under ambient light to allow for further 
band development. 
Gels were scanned and band size and intensity compared using ImageJ software. 
 
5. HIF 1α EXPRESSION QUANTIFICATION 
We compared HIF 1-α expression in protein extracts from 4T1 cells in the following 
conditions: 
 Control cells incubated for 16 hours in normoxia followed by 8 hours in hypoxia 
(5% oxygen) 
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 Catalase transfected cells incubated for 16 hours in normoxia followed by 8 
hours in hypoxia (5% oxygen) 
 Control cells incubated for 24 hours in normoxia (21% oxygen) 
 
Fig. 8: Experimental design for quantification of HIF 1α in normoxia and hypoxia. 
 
5.1 Protein extraction 
To obtain an extract of whole cell protein, the RIPA lysis and extraction buffer was 
used, complemented with protease inhibitors to minimized protein degradation. 
Cell culture dishes were placed on ice, cell growth media was removed and cells were 
washed with ice-cold PBS. Cells were scraped from the dish using a rubber policeman 
in approximately 10 µl/cm2 growth area of PBS and remaining cells were washed from 
the surface using the same amount of PBS. The collected cells were centrifuged at 
5000 g, 4ºC for 5 minutes. The supernatant was removed and cells were resuspended 
in RIPA lysis buffer in the presence of protease inhibitors (benzamidin, leupeptin, 
pepstatin, PMSF and DTT) and incubated on ice for 10 minutes. The lysate was then 
centrifuged at 15000g, 4ºC for 15 minutes. The supernatant containing the protein 
extract was collected and stored at −80 °C. 
Protein was quantified as described in section 4.2. 
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5.2 Immunoblotting 
Immunoblotting makes use of antibodies to bind and visualize a specific protein in a 
protein extract after it has been subjected to separation by polyacrylamide gel 
electrophoresis. 
Equal amounts of proteins (40-70 µg) from each sample and 4 µl of loading buffer were 
mixed and distilled water was added to a final volume of 30 µl. The LMW protein 
ladder (GE Healthcare) was used to determine protein sizes.  
Samples were heated at 90ºC for 5 minutes and then loaded onto a polyacrylamide gel 
consisting of 5% stacking gel and 8% separating gel (Maniatis, Fritsch et al. 1982). The 
gel was run at 100 V in running buffer for approximately 80 minutes. 
Gels were equilibrated in transfer solution and electroblotted to nitrocellulose 
membranes using semi-dry blot transfer cell (BioRad) for 1 hour at 2 mA/cm2 of 
membrane. 
Protein transfer was observed by coloring the membrane with Ponceau solution. The 
membranes were then blocked for 1 h in TBS buffer (pH 7.4) containing 0.1% Tween-20 
(Sigma) and 3% powdered milk protein and then incubated overnight at 4 °C with the 
HIF 1α antibody (MAB1536 from R&D systems) diluted 1:500 in blocking solution. 
Membranes were washed three times with TBS containing 0.1% Tween-20 (Sigma) and 
incubated for two hours with a 1:5000 dilution of secondary antibody coupled to 
horseradish peroxidase in TBS containing 0.1% Tween-20 and 3% powdered milk 
protein. Protein bands were then detected by chemiluminescence, using the ECL Prime 
detection kit from GE healthcare and visualized using Imagequant LAS 500 (GE 
healthcare). 
 
6.  ANALYSIS OF GENE EXPRESSION USING QUANTITATIVE RT-PCR 
Gene expression in control and cell populations transfected with exogenous catalase 
was compared by extracting total RNA, synthesizing cDNA and performing quantitative 
real-time PCR. 
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Fig. 9: Experimental design for gene array analysis of control and catalase transfected cell 
populations. 
 
6.1 RNA extraction 
Total RNA extraction was performed using Trizol reagent (Invitrogen) following 
manufacturers’ instructions. Briefly, cells were washed with ice cold PBS and Trizol was 
added (1 ml/20 cm2 of cell culture plate). Cells were lysed by pipetting and the mixture 
was incubated at room temperature for 5 minutes. Then chloroform was added at a 
ratio of 0.2 ml/(ml of Trizol) and tubes were vortexed vigorously for approximately 15 
seconds and left at room temperature for another 3 minutes. This was followed by 
centrifugation at 12000 g for 15 minutes at 4ºC to obtain phase separation. The 
aqueous phase (supernatant) containing the RNA was carefully removed to a new tube 
and isopropanol was added at a rate of 0.5 ml/(ml of Trizol) to precipitate RNA. 
Solution was mixed by gentle inversion and left at room temperature for 10 minutes. 
This was followed by centrifugation at 12000 g for 10 minutes at 4ºC to obtain the RNA 
pellet. The pellet was washed using 1 ml of ethanol 75% followed by centrifugation at 
7500g for 5 minutes at 4ºC. All supernatant was removed and the pellet was let dry for 
a few minutes before being resuspended in nuclease-free water. 
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cDNA synthesis 
Quantitation of angiogenesis related transcripts by real-time PCR 
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Genomic DNA was eliminated by digestion with DNAse (Thermo Scientific). The 
following reagents were added and the mix incubated at 37ºC for 30 minutes. 
Reagent Quantity 
DNAse buffer (10x)  3 µl 
RNA 1 µg 
RiboLock, RNAse inhibitor (20 U/µl) 1 µl 
DNAse (1 U/µl)   3 µl 
ddH2O, nuclease-free To 30 µl 
 Table 4: Reagents used for DNA digestion in total RNA extracts. 
 
After incubation, 3 µl of 50 mM EDTA were added followed by an incubation at 65ºC 
for 10 minutes to inactivate the DNAse.  
RNA was quantified using Nanodrop 1000-1000 and its integrity observed in 1% 
agarose gel. 
A PCR for a house-keeping GAPDH gene sequence was used to ascertain there was no 
residual genomic DNA contamination. 
For each sample plus a negative (containing water) and a positive (containing mouse 
cDNA) controls the following reagents were used: 
Reagent Quantity 
DreamTaq polymerase buffer (10x)  2 µl 
dNTPs (10 mM) 2 µl 
Forward Primer for GAPDH (10 µM) (ThermoScientific) 0,2 µl 
Reverse Primer for GAPDH (10 µM) (ThermoScientific) 0,2 µl 
RNA  200 µg 
DreamTaq polymerase (5U/µl) (ThermoScientific) 0,25 µl 
ddH2O, nuclease-free To 20 µl 
Table 5: Reagents used for PCR for the house-keeping gene GAPDH to verify there is no 
DNA contamination in total RNA extracts. 
 
The PCR program (in a PTC-100 thermocycler) used was: 
Denaturation        95ºC      5 min 
Denaturation        95ºC      1 min 
Annealing              60ºC      1 min 30s 
Extension               72ºC      1 min 
Extension               72ºC    10 min 
 
PCR products were visualized in 1% agarose gel. 
X 34 
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6.2 cDNA synthesis 
cDNA was obtained from extracted RNA using the RevertAid H minus first strand cDNA 
synthesis kit (Thermo scientific) according to manufacturer’s instructions. 
For each sample plus a negative (containing water) and a positive (GAPDH RNA) 
controls the following reagents were used: 
Reagent Quantity 
RNA 0,5 µg 
Random hexamer primer 1 µl 
Reaction Buffer (5x) 4 µl 
dNTPs (10 mM) 2 µl 
RiboLock RNase Inhibitor (20 U/µl) 2 µl 
RevertAid H Minus M-MuLV Reverse Transcriptase (200 U/µl)  1 µl 
ddH2O, nuclease-free To 20 µl 
Table 6: Reagents used for cDNA synthesis from total RNA extracts using the RevertAid H 
minus first strand cDNA synthesis kit (Thermo scientific). 
 
Reaction tubes were placed in a thermocycler and incubated at 25ºC for 5 minutes to 
allow for random primer annealing, 50ºC for 30 minutes for cDNA synthesis and finally 
at 85ºC for 5 minutes to inactivate the enzyme, thus stopping the reaction. 
cDNA was stored at -20ºC until use. 
 
6.3 Real Time RT-PCR 
Real time reverse-transcriptase PCR is used to quantify the RNA amplified by a given 
set of primers in comparison to a control one. This allows for a quantitative 
comparison of gene expression in a set of different RNA samples, after normalization 
using an equally expressed control gene sequence. The addition of SYBR Green, which 
emits fluorescence after binding to double stranded DNA allows us to follow the 
quantity of PCR product amplified, which correlates with the initial RNA present in the 
sample.    
We used Real Time RT-PCR to compare cDNAs obtained from our control plasmid 
transfected cells and from our catalase plasmid transfected cells. The RT² Angiogenesis 
Profiler™ PCR Array System for mouse by SABiosciences, which compares the 
expression of 84 genes involved in modulating the biological processes of 
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angiogenesis, including growth factors, receptors, transcription factors, cytokines and 
matrix related proteins in a total of 4 samples was used for the initial screening. 
One control cDNA combining 500 µg RNA from 3 different control samples was 
compared with 3 cDNAs from 3 different catalase containing samples. Original cDNAs 
were diluted 1:6 using nuclease-free MQ water. Mixes were prepared as per 
manufacturers’ instructions: 
Components Volume (µl) 
2X SABiosciences RT2 qPCR Master Mix 550 
Diluted First Strand cDNA Synthesis Reaction  102 
ddH2O 448 
Total Volume  1100 
Table 7: Reagents used for gene array analysis using the RT² Angiogenesis Profiler™ PCR 
Array System (SABiosciences). 
 
For each sample 10 µl of mix was pipetted into each well. RT-PCR was performed in a 
CFX384 Real-Time System (Bio-rad). 
Results were analyzed using β-actin as reference and fold changes were determined in 
relation to the control sample. Genes of interest were considered based on total fold 
change, reproducibility of result and possible role in our in vivo assays. 
Validation of the gene array results was done for each gene of interest (bai1, hey1, 
thbsp1, timp3). An RT-PCR was done for 8 different controls and 8 different catalase 
transfected cell cultures, using 18S as reference and the following primers: 
Gene  Primer ID Sequence 5’3’ 
Bai1 
mBai1F GGATGTGGATCTGGCCTGTAG 
mBai1R TCGCTTGAAGGTACCTGTGATAGT 
Hey1 
mHey1F GCGCACGCCCTTGCT 
mHey1R GCCAGGCATTCCCGAAAT 
Thbs1 
mThbs1F CTGCAAAGGAATGCATGCTAAT 
mThbs1R CCACGGCTGCCATGGT 
Timp3 
mTIMP3F CCAACATCTTTTCCATCTTAATCCA 
mTIMP3R CCATGTAAAAGGGAGGTGATTACC 
Table 8: Primers used for RT-PCR confirmation of gene array results for genes 
bai1, hey1, thbsp1 and timp3. 
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cDNAs were diluted 1:3 and a calibration curve using further dilutions between 1:10 
and 1:10000 was done for each gene. A control without cDNA template was also used 
for each gene. The following components were added: 
Components Volume (µl) 
Sybr Green 7,5 
Forward primer (10 µM) 0,45 
Reverse primer  (10 µM) 0,45 
ddH2O 5,6 
Total volume 14 
Table 9: Reagents used for RT-PCR confirmation of gene array results for genes 
bai1, hey1, thbsp1 and timp3. 
 
This mix and 1 µl of diluted cDNA were added to each well and RT-PCR was performed 
in a CFX384 Real-Time System (Bio-rad). 
Results were analyzed using 18S as reference and fold changes were determined in 
relation to the control samples. 
 
7.  IMMUNOCYTOCHEMISTRY FOR BAI1,  T IMP3,  THBS1  AND CATALASE  
In this technique, antibodies specific to proteins of interest are used to observe 
differences in protein expression and cellular localization. 
Specifically, we used antibodies for the proteins with significant fold-changes in 
expression as detected by RT-PCR, to visualize these changes within the cells as well as 
catalase antibody to observe catalase overexpression  
Antibodies used were BAI1 antibody (NBP1-00723), TIMP3 antibody (NB110-61002), 
Thrombospondin1 A4.1 (NB600-554) all from Novus Biologicals and catalase (H-300) 
from Santa Cruz Biotech.  
 
Cells were seeded over coverslips and the following conditions were tested: 
a) 4T1 cell cultures transfected with catalase or transfected with control plasmid, 
24 hours after transfection. 
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b) 4T1 cell cultures grown for 24 hours in conditioned media from cultures 
transfected with catalase or transfected with control. 
c) 4T1 cell cultures grown for 24 hours in media containing extracellular catalase 
in the following amounts: 10U/ml, 50U/ml, 100U/ml and 250U/ml 
 
a)                                                                                         b) 
                                                                                                    
 
 
 
 
 
 
c)  
 
 
 
 
Fig 10: Experimental design for immunofluorescence studies. Experiment a) analyses 
differences in control vs catalase transfected cells, experiment b) analyses differences in 
cells incubated with conditioned media from experiment a) and experiment c) analyzes 
the effect of extracellular catalase on the expression of target proteins. 
 
Cells were washed 3 times with PBS, fixed in 4% PFA (paraformaldehyde) for 30 
minutes at room temperature and again washed 3 times with PBS. For TIMP3 and 
Thrombospondin1, which have a cytoplasmic localization, cells were permeabilized by 
incubating in a PBS 0,5% Triton solution for 20 minutes at room temperature.  
Blocking was done with PBS 10% FBS for approximately 1 hour at room temperature 
after which the appropriate primary antibody was added after being diluted 1:100 in 
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PBS 10% FBS. These preparations were left at 4ºC O/N in a humid environment to 
prevent the cells drying out. 
Cells were again washed 3 times for 5 minutes each with PBS and then incubated with 
the appropriate secondary antibody conjugated with a fluorescent dye (anti-rabbit or 
anti-mouse Alexa Fluor® 488 (Invitrogen)) for 2 hours at room temperature in the dark. 
Cells were again washed with PBS and stained with DAPI as described in section 2.3. 
The coverslips were mounted on a lamella with mowiol® (Sigma-Aldrich) and cells were 
observed using an Olympus BX60 microscope with 40x amplification. Excitation 
wavelengths of 530-550 were used for mCherry, 470-490 for Alexa Fluor 488 and 330-
385 for DAPI. 
For quantification of percentage of positive cells, random fields were photographed 
and those with 3 or more positive cells were chosen. The number of positive cells/total 
of cells was determined for each field and the average and standard deviation for each 
experiment was calculated using Excel as was p-value for each condition. 
 
8. IN SITU HYBRIDIZATION ANALYSIS OF NOTCH PATHWAY GENE EXPRESSION 
 
We used digoxigenin-labelled RNA probes with complementary sequences to several 
genes involved in the notch pathway to perform in situ hybridization followed by 
immunocytochemistry of catalase in order to compare gene expression and catalase 
expression.   
The plasmid encoding the probe for Hey2 was a gift from Dr. A. Duarte and the 
prepared probes for Hey1, Dll1, Dll4, Jagged1, Notch1, Notch3, Hes1, Hes5 and Hes6 
were a gift from Dr.  D. Henriques  (IMM, Lisbon). 
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Fig. 11: Experimental design for in situ analysis of notch pathway gene transcripts in 
control and catalase transfected cells.  
 
 
8.1 RNA probe preparation 
The linearized plasmid was quantified using Nanodrop 1000 and diluted to 1μg/μl. The 
RNA probe was synthesized using the Riboprobe® in vitro transcription system 
(Promega) with the following quantities: 
Components Volume (µl) 
Transcription buffer (5x) 4 
DTT (100 mM) 2 
rATP, rGTP, rCTP and DIG-11-UTP 
(2.5mM each) mix 
4 
RNAsin 1 
RNA polymerase 1 
Plasmid DNA 1 
ddH2O, nuclease-free 7 
Total volume 20 
Table 10: Reagents for synthesis of digoxigenin-labelled RNA probe  
The mixture was incubated at 37ºC for 1 hour.  After synthesis, DNA was removed by 
adding 1 μl DNAse (Thermoscientific) and 1μl RNAsin and incubating at 37ºC for 
another 15 minutes. 
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The solution was diluted to 100 μl and the RNA was precipitated with 10 μl of LiCl 4M 
and 300 μl of ethanol and left at -20ºC overnight. The RNA was recovered by 
centrifugation at 16000g for 30 minutes at 4ºC followed by washing with 75% ethanol 
and resuspended in TE. 
RNA integrity was confirmed by running a sample in a 1% agarose gel. 
 
8.2 In situ hybridization 
For in situ analysis cells were transfected as described before in 24-well plates. 24 
hours after transfection, media was removed and cells were washed twice with a 
PBS/EGTA solution with pH 7,5 and then fixated with formaldehyde 4% in PBS/EGTA 
for 2 hours at room temperature. After fixation cells were washed for 5 minutes in PBT 
twice and next dehydrated 5 minutes in 50% methanol/PBT and 5 minutes in 100% 
methanol twice. Fixated cells were stored in methanol at -20ºC for up to 2 weeks. 
Cells were rehydrated by incubating for 5 minutes in each of the following solutions: 
75%, 50% and 25% methanol/PBT and then washed twice for 5 minutes in PBT. 
Cells were washed with a solution of PBT/hybridization mix (1:1) followed by rinsing 
several times with hybridization mix and finally incubating the cells in hybridization mix 
at 70ºC for 2hours. 
Each probe was diluted in hybridization mix to a final concentration of 0,5 mg/ml, pre-
heated to 70ºC and cells were left in this solution overnight at 70ºC. After rinsing with 
mix hybridization, cells were washed with hybridization mix twice for 40 minutes 
followed by 30 minutes with a hybridization mix/MABT (1:1) solution at 70ºC with 
gentle agitation. 
Cells were washed a further 3 times for 30 minutes with MABT (maleic acid buffer 
containing Tween 20) at room temperature followed by blocking in a 2% blocking 
reagent (Roche), 20% sheep serum in MABT solution for 2 hours. Cells were then 
incubated with alkaline phosphatase conjugated anti-digoxigenin antibody (Roche) 
diluted 1:2000 in the same solution overnight at 4ºC. 
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Cells were washed 4 times for 1 hour in MABT followed by 2 washes of 10 minutes 
with freshly prepared NTMT and then incubated with the substrates NBT/BCIP 
(Promega) until color detection after which the reaction was stopped by washing with 
PBT. Catalase overexpression was detected by immunofluorescence as described in 
section 7. 
 
9. CLONING OF THE PBRTOL-2-FLK1-KALTA4ERT2 PLASMID 
In order to obtain a transgenic Zebrafish overexpressing catalase in endothelial cells 
upon external stimulation tg(flk1:KalTA4), a combination of the Gal4ff-UAS-system, 
estrogen receptor sensitive to tamoxifen and endothelial specific promoter flk1 were 
cloned into a Tol-2 transposon system. 
In this system, a plasmid containing a Tol-2 sequence (Urasaki, Morvan et al. 2006) and 
a Gal4 sequence optimized for use in Zebrafish, named KalTA4 (Distel, Wullimann et al. 
2009), with the sequence for the estrogen receptor ERT2 downstream and preceded 
by the flk1 promoter sequence acts as the activator construct. 
A similar plasmid containing a Tol-2 sequence, the UAS to which Kalt4 binds followed 
by the human catalase and mCherry genes is the effector construct and will be used to 
create the transgenic tg(UAS:catalase). By crossing these 2 lines, the transgenic 
tg(flk1:KalTA4; UAS:catalase) will be obtained where, upon tamoxifen addition, KalTA4 
activator transactivates UAS dependent genes, resulting in this case in both catalase 
and mCherry protein production. 
Because KalTA4 expression is promoted by flk1, the activator is present only in 
endothelium, giving catalase overexpression cell type specificity. 
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Fig. 12: Experimental design for creating a Zebrafish transgenic to express catalase in 
endothelial cells in a time-controlled manner. The tg(flk1:KalTA4) line will be crossed 
with tg(UAS:catalase) and in presence of tamoxifen tg(flk1:KalTA4; UAS:catalase) will 
express catalase in endothelium. 
 
Additionally, the KalTA4 activator transcription is tamoxifen inducible because it is 
fused to an estrogen receptor (ERT2) sequence. The protein Hsp90 binds to ERT2 in the 
cytoplasm, inactivating it. When tamoxifen, an estrogen analog, is added, it binds to 
ERT2 causing the translocation of the entire sequence to the nucleus where 
transcription factors bind to the flk1 promoter leading to KalTA4 transcription.  
KalTA4 will then bind to the UAS sequence leading to transcription of both catalase 
and mCherry in endothelial cells in a time-controlled and site-specific manner (Hans, 
Kaslin et al. 2009). 
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Fig. 13: Mechanism of tamoxifen dependent catalase overexpression in Zebrafish 
endothelial cells. Catalase expression in endothelial cells using the KalTA4 system is 
dependent upon addition of tamoxifen to Zebrafish embryo media which leads to 
translocation of the flk1 promoter to the nucleus and subsequent translation of KalTA4 
which then binds to the UAS sequence activating transcription of catalase and mCherry. 
 
Our strategy for cloning the pBRTol-2-flk1-KalTA4ERT2 plasmid was to obtain the flk1 
fragment by digesting pCRIITopo-flk1 with the restriction enzymes XhoI and EcoRV, 
amplify the KalTA4-ERT2 sequence on pCS2 using the sp6 and T3 universal primers 
followed by a NotI digestion and do a triple ligation with these fragments and the pBR-
Tol2 vector digested with XhoI and NotI (Fig. 15) 
 
Fig.14: Map of plasmid pBRTol2-flk1-KalTA4-ERT2. Sites denoting the restriction enzymes 
used for cloning are indicated.  
The fragments obtained were purified, the KalTA4-ERT2 fragment was phosphorylated 
at its 3’ blunt end and the pBRTol2 vector was dephosphorylated after digestion to 
minimize relegation and false positive transformants. 
The detailed cloning strategy is presented schematically in Fig. 15 below. 
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Fig. 15: Experimental design for cloning of the pBRTol2-flk1-KalTA4-ERT2 plasmid. 
 
9.1 E. coli culture 
The E. coli (DH5t strain) were grown in LB media supplemented with 100 mg/ml 
ampicillin for the cells containing the pCRIItopo or the pCS2 plasmid and 20 mg/ml for 
the cells containing the pBR- Tol2 plasmid, which is a low-copy number plasmid, O/N at 
37ºC with 200 rpm agitation. 
 
9.2 Plasmid DNA extraction 
Plasmid DNA was extracted using the Wizard® Plus SV Miniprep kit from Promega 
following manufacturers’ instructions. Briefly, 3 ml of bacterial culture were 
centrifuged at 16000g for 5 minutes. The supernatant was discarded and the cells 
resuspended by vortexing in 250 μl of resuspension solution. The same volume of lysis 
solution was added and the suspension was gently mixed after which 10 μl of alkaline 
protease solution was mixed in by inversion and left to incubate for 5 minutes at room 
temperature. The reaction was stopped by adding 350 μl of neutralization solution and 
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bacterial debris collected by centrifugation at 16000g for 10 minutes. The resulting 
lysate was poured into a spin column which was centrifuged at 16000g for 1 minute. 
The column was then washed twice with 750 μl and 250 μl of wash solution followed 
by similar centrifugation steps. The spin column was then transferred to a sterile tube 
and 100 μl and 50 μl, for high copy number and for low copy number plasmids, 
respectively, were added followed by centrifugation at 16000g for 1 minute to collect 
the plasmid DNA. 
The plasmidic DNA concentration was measured using the Nanodrop 1000.  
 
9.3 DNA fragment amplification by PCR 
The KalTA4-ERT2 fragment was amplified using the sp6 and T3 primers in the pCS2 
plasmid with the following sequences: 
Name 5’3’ sequence 
SP6 AAGCTTGATTTAGGTGACACTATAG 
T3 CAATTAACCCTCACTAAAGGGA 
Table 11: Sequence of primers sp6 and T3 used to amplify the KalTA4-ERT2 
fragment. 
 
For the PCR the following reagents were used: 
Reagent Quantity 
Phusion buffer (5x) Thermo Scientific 4 µl 
dNTPs (10 mM) 0,4 µl 
sp6 primer (10μM) 1 µl 
T3 primer (10 µM)  1 µl 
pCS2-KalTA4-ERT2 DNA (1 ng/μl) 1 µl 
Phusion DNA polymerase (2U/µl) (ThermoScientific) 0,2 µl 
ddH2O, nuclease-free To 20 µl 
Table 12: Reagents used for the PCR amplification of the KalTA4-ERT2 fragment. 
The PCR program (in a PTC-100 thermocycler) used was: 
Denaturation        98ºC    30 sec 
Denaturation        98ºC    15 sec 
Annealing              60ºC    1 min 30 sec 
Extension              72ºC     1 min 30 sec 
Extension              72ºC     10 min 
 
The PCR product was visualized in 1% agarose gel. 
X 29 
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9.4 DNA precipitation 
The PCR product and digestion products solution in intermediate steps were 
precipitated to remove salts and proteins before further steps were carried out. This 
was done by adding 1/10 of the solution volume of sodium acetate 3M and twice the 
solution volume of ethanol 96% and putting the mixture at -20ºC O/N. The following 
day, tubes were centrifuged at 16000g, 4ºC for 30 minutes and the supernatant 
removed. 500 μl of ethanol at 70% was added followed by centrifugation at 16000g, 
4ºC for 10 minutes. The supernatant was thoroughly removed, the pellet left to air dry 
for a few minutes and then resuspended in an appropriate volume of MQ water.    
 
9.5 DNA fragment restriction enzyme digestions  
The double digestion to obtain the flk1 fragment was performed by adding the 
following reagents: 
  Reagent Quantity 
Buffer 3 (10x) New England Biolabs 10 µl 
BSA (100x) New England Biolabs 1 µl 
XhoI (10 U/μl) Fermentas 4 µl 
EcoRV (20 U/µl) Fermentas 2 µl 
pCS2-flk1 DNA (1850 ng/μl) 2,16 µl (4 μg) 
ddH2O, nuclease-free To 100 µl 
Table 13: Reagents used for the digestion of the pCRTopo plasmid in restriction 
sites flanking the flk1 promoter. 
 
The digestion mix was incubated at 37ºC O/N. 
 
For the double digestion of the pBRTol-2 vector the following reagents were added: 
  Reagent Quantity 
Buffer 3 (10x) New England Biolabs 10 µl 
BSA (100x) New England Biolabs 1 µl 
XhoI (10 U/μl) Fermentas 4 µl 
NotI (10 U/µl) New England Biolabs 4 µl 
pBR Tol2 DNA (273 ng/μl) 14,6 µl (4 μg) 
ddH2O, nuclease-free To 100 µl 
Table 14: Reagents used for the digestion of the pBRTol2 plasmid vector. 
The digestion mix was incubated at 37ºC O/N. 
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For the digestion of the PCR fragment containing KalTA4 and ERT2 the following 
reagents were added: 
  Reagent Quantity 
Buffer 3 (10x) New England Biolabs 10 µl 
BSA (100x) New England Biolabs 1 µl 
NotI (10 U/µl) New England Biolabs 4 µl 
KalTA4 PCR product (187,7 ng/μl) 21 µl (4 μg) 
ddH2O, nuclease-free To 100 µl 
Table 15: Reagents used for the digestion of the KalTA4-ERT2 fragment amplified 
by PCR. 
 
The digestion mix was incubated at 37ºC O/N. 
The digestion products KalTA4 and pBRTol-2 were precipitated as described above and 
flk1 was purified by gel. 
 
9.6 Dephosphorylation of the pBRTol-2 vector 
After precipitation, the pDNA was resuspended in 43 μl of MQ water to which 5 μl of 
Antarctic phosphatase buffer (10x) and 2 μl of Antarctic phosphatase (both from New 
England Biolabs) were added. The mix was incubated for 1 hour and 30 minutes at 
37ºC. 
 
9.7 Phosphorylation of KalTA4 fragment  
After precipitation, the KalTA4 fragment resuspended in 15 μl of MQ water to which 2 
μl of Buffer A (10x), 2 μl of ATP (10μM) and 1 μl of T4 kinase (10 U/μl) 
(Thermoscientific). The mixture was incubated at 37ºC for 30 minutes followed by 10 
minutes at 75ºC to inactivate the enzyme. 
 
9.8 DNA purification by gel extraction 
DNA fragments were ran on a 1% agarose gel at 90V for approximately 30 minutes, 
bands of interest were excised by comparing band size with the Generuler 1 Kb DNA 
ladder (Thermoscientific) and purified using the Wizard® SV gel and PCR clean-up 
system from Promega. Briefly, the excised band was weighed and 10 μl of membrane 
binding solution per 10 mg of gel was added, the mixture was vortexed and incubated 
Materials and methods 
 
   44 
at 55ºC until the gel dissolved. The mixture was then transferred to the SV minicolumn, 
left to incubate for 1 minute at room temperature and centrifuged at 16000g for 1 
minute. The flowthrough was discarded and the column was washed twice, with 700 
μl, followed by a 1 minute centrifugation at 16000g, and 500 μl of membrane wash 
solution followed by a 5 minute centrifugation at 16000g. The DNA was eluted by 
adding 30 μl of MQ water to the column, incubated for 1 minute and centrifuged at 
16000g for 1 minute and stored at -20ºC. 
 
9.9 DNA quantification  
DNA fragments were quantified by running 1 μl of purified solution in a 1% agarose gel 
and comparing with the Generuler 1 Kb DNA ladder (Thermoscientific).  
 
9.10 Ligation 
The appropriate amounts of each fragment plus 1 μl of ligation buffer 10x (Fermentas) 
and 1μl of ligase (Fermentas) and MQ water to a total of 10 μl were added and 
incubated at 16ºC O/N. 
 
9.11 Competent E. coli by the Inoue method 
The DH5t E. coli strain was used to make competent cells for transformation (Inoue, 
Nojima et al. 1990). Cells were streaked in an agar-LB plate without antibiotic and 
incubated O/N at 37ºC. A pre-culture with 25 ml of SOB supplemented with 10 mM 
MgCl2 and 10 mM MgSO4 and inoculated with a single colony from the plate was 
incubated O/N at 37ºC and 250 rpm. The following day, 1 ml of pre-culture was used to 
inoculate 125 ml of SOB supplemented as described above and incubated at 18ºC, 250 
rpm for 24-26hours. 
After 24 hours incubation, O.D. of the culture was measured at 600 nm, starting at 30 
minutes intervals and diminishing as O.D. increased. When O.D. reached 0,6, the 
culture was iced for 10 minutes, then placed in a sterile centrifuge flask and 
centrifuged at 2500g, 4ºC for 10 minutes and the supernatant removed. The cells were 
very gently resuspended in 40 ml of chilled transformation buffer and incubated on ice 
for another 10 minutes followed by  centrifugation at 2500g, 4ºC for 10 minutes. The 
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supernatant was removed and the cells resuspended in 10 ml of chilled transformation 
buffer. DMSO (dimethyl sulfoxide) to a final concentration of 7% was added and 
aliquots of 100 μl were made and immediately frozen in liquid nitrogen. Cell aliquots 
were stored at -80ºC. 
 
9.12 Transformation  
An aliquot of competent bacteria was slowly thawed and ligation mix was added to the 
cells, gently mixed and placed on ice for 20 minutes. A control with 1 μl of digested 
and dephosphorylated vector plasmid DNA was used following the same procedure. 
The mixtures were then placed in a water bath at 42ºC for 90 seconds and immediately 
put on ice for another 5 minutes after which 900μl of LB media were added to each 
tube. The cultures were incubated for 1 hour at 37ºC, 200 rpm. After incubation, cells 
were centrifuged at 5000g for 2 minutes and 900μl of supernatant were removed. 
Cells were resuspended in the leftover media and then spread in an LB-agar containing 
20 mg/ml of ampicillin plate and incubated at 37ºC O/N. 
 
9.13 Testing for the pBRTol2-flk1-KalTA4-ERT2 plasmid in transformants  
Single colonies were picked from the transformants plate and grown in 5 ml LB with 20 
mg/ml ampicillin at 37ºC, 250 rpm O/N. Cultures were centrifuged at 15000g for 10 
minutes and the supernatant discarded. Approximately 5 μl of pellet were added to 20 
μl of cracking buffer and incubated at 55ºC for 30 minutes followed by vortexing for 1 
minute. DNA was visualized in a 1% agarose gel and transformants with bands over 
10000 bp were selected for further testing. Plasmidic DNA was extracted from the 
remaining pellet using the Wizard® Plus SV Miniprep kit as described previously and 
different restriction enzyme digestions were used to check for the presence of the 
relevant fragments. 
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RESULTS 
 
Previous results obtained in our laboratory (Rodrigues, G., Ms Thesis, 2011) have shown that 
lower levels of H2O2 in tumor cells, due to transient catalase overexpression, affect in vivo 
angiogenesis.  
The present work focused in identifying the molecular mechanisms involved in the crosstalk 
between tumor cells and endothelial cells that may be responsible for the observed 
phenotype.  
 
1. CATALASE OVEREXPRESSION IN 4T1 CELLS 
In order to identify tumor cells with catalase overexpression, we created a plasmid that co-
expressed a reporter protein, mCherry, as well as catalase in the same cell. We have also 
optimized the transfection procedure for 4T1 cell line.  
 
1.1. Cloning catalase in pCIC-IRES-mCherry-NLS  
A construct containing catalase and the fluorescent protein mCherry was made using the 
pCIC-IRES-mCherry-NLS plasmid (fig. 16). 
 This vector allows the independent expression of catalase and mcherry in the same cell 
without the production of a fusion protein. This plasmid will be referred to as pCIC-Cat (pCIC-
Catalase-IRES-mCherryNLS). 
The vector contains mCherry with an NLS (nuclear localization sequence) which directs the 
fluorescent protein towards the nucleus. The presence of an IRES sequence (independent 
ribosome entry site) downstream of the gene of interest enhances mCherry translation to 
ensure that all cells expressing catalase will also express the reporter gene. 
 In the subsequent experiments the plasmid containing only the mCherry sequence, here 
referred to as pCIC, was used as control. 
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Fig. 16: Construction of pCIC-Cat plasmid for catalase overexpression. pCIC-Cat allows the 
independent overexpression of catalase and mCherry (IRES: independent ribosome entry site, 
NLS: nuclear localization sequence).  
 
1.2 Optimization of 4T1 cell transfection 
 
Due to the low transfection efficiency of the previously developed method (7,07 ± 2,53%) it 
was necessary further optimization. 
The transfection reagents Lipofectamine® 2000 (Invitrogen) and Fugene® 6 (Promega) were 
tested using the plasmid pCIC and an initial screening of best cell density and DNA/liposome 
ratio was performed by comparing variations in mCherry fluorescence using a microplate 
reader (fig. 17) 
 
Fig. 17: Relative fluorescence obtained with different transfection protocols using Fugene6 and 
Lipofectamine 2000 reagents. Fluorescence at 610nm was measured 24 hrs after transfection 
with pCIC-Cat. Data labels represent the transfection reagent to DNA ratio in μl/μg.  
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The best transfection conditions were further tested with cell transfection being determined 
by cell counting using fluorescence microscopy and FACS.  
The best condition used lipofectamine as transfection reagent in a 1:1 ratio of (μl 
lipofectamine):(μg DNA) and cells seeded at 2,5x104 cells/cm2 16 hours before transfection 
and yielded a transfection efficiency of 16,7 ± 2,78% in contrast with 7% initially obtained.
 
 
 
1.3 Catalase expression and activity in 4T1 cells transfected with pCIC-Cat  
 
To confirm catalase expression in mCherry positive cells we have performed 
immunofluorescence. 
 
Fig. 18: Catalase expression in 4T1 cells transfected with pCIC-Cat. Immunocytochemistry of 
4T1 cells transfected with mCherry and catalase.  mCherry (red) positive cells present 
overexpression of catalase (green) when compared with non-transfected cells (stained blue 
using DAPI).  
 
The cells transfected with the pCIC-Cat plasmid (referred to as CatO cells) presented an 
increase in catalase expression compared with mcherry negative cells (fig.18).  
 
Catalase is a multimeric protein containing four subunits whose assembly is necessary for 
enzymatic activity. To verify whether the catalase overexpressed was functional in 
transfected cells, catalase activity was measured by a zimography assay. This was achieved 
by protein separation in native gel, followed by observation of hydrogen peroxide 
consumption using a chromogenic product (Materials and methods section 4).  
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Control   Catalase 
8 hours 
16 hours 
24 hours 
Time after transfection 
The protein extract used for this assay was obtained at 8, 16 and 24 hours after transfection, 
to determine the best end time for further experiments. The highest increase in catalase 
activity was achieved 24 hours post-transfection and this timepoint was chosen for 
subsequent experiments.  
 
Fig. 19: Catalase activity in 4T1 cells transfected with pCIC-Cat at different timepoints.  
(A)Hydrogen peroxide presence was detected by gel staining. Catalase activity corresponds to 
higher level of stain fading. (B). catalase activity quantification (P<0,05, n=3).  
 
2. HIF1α expression in 4T1 cells in vitro  
 
In hypoxic conditions (5-10% oxygen), HIF1α is the key regulator of angiogenesis and is 
known to be regulated by H2O2.  
In this work we were interested in finding H2O2 targets that are independent of HIF1α 
regulation and so we determined HIF 1α expression by western blot. We compared the 
expression of HIF 1α in protein extracts from 4T1 in normoxia and in hypoxia (5% oxygen) 
and also confirmed the effect of catalase overexpression on HIF 1α in the 4T1 cell line. 
 
Fig. 20:  Western blot of HIF 1α. HIF 1α expression in hypoxia (5% O2) in 4T1 control cells, in 
hypoxia in 4T1 CatO cells and in normoxia in 4T1 control cells.   
A B 
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We observed that, in normoxia, HIF 1α expression is too low to detect. In addition, 
overexpression of catalase is enough to decrease the overall amount of HIF1α when 
compared to control cells, as previously described (Brunelle, Bell et al. 2005). 
 
The negligible effect of HIF1 in tumor cells cultured in normoxia conditions (21% oxygen) 
allows for the study of other factors controlled by H2O2, which are independent of HIF1α 
regulation. 
 
3. H2O2-dependent regulation of gene expression in the 4T1 cell line  
In order to test whether the reduction in H2O2 cellular levels affected the expression of 
genes known to be involved in the angiogenic process, we used a PCR-Array focused on pro 
and anti-angiogenic genes.  
 
Figure 21 presents the gene expression ratio between CatO cells and control cells.  
 
Fig. 21: Angiogenesis related genes expressed in CatO 4T1 cells. The genes with an average 
mRNA expression change > 2 fold from 3 independent samples transfected with catalase vs 
control cell cultures are represented. 
 
The function of genes present in Figure 21 are is described in table 16 in supplementary 
materials. 
Of note, several overexpressed genes, namely brain-specific angiogenesis inhibitor 1, 
chromogranin A, Collagen, type IV, alpha 3 and plasminogen are precursors to smaller 
molecules that act as angiogenesis inhibitors after cleavage and can thus contribute to the 
phenotype observed in vivo. From these, we choose to analyze the role of brain-specific 
* 
* 
* 
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angiogenesis inhibitor 1 (Bai1), thrombospondin 1 (Thbs1) and tissue inhibitor of 
metalloproteinase 3 (Timp3) as they have antiangiogenic properties and were significantly 
upregulated in CatO cells. In this first analysis, we excluded Ptn since it mainly expressed in 
brain tissue and Il12a that functions as antiangiogenic and was found to be downregulated. 
Although Hey1 and Hey2 expression was not significantly different between CatO cells and 
control cells, we decided to analyze the components of notch signaling pathway since they 
have a central role in the regulation of vessel formation and branching.  
In order to validate some of the results obtained in the gene analysis, we performed an RT-
PCR using control and catalase transfected 4T1 cells. 
 
  
Fig. 22: Quantification of the expression of angiogenesis related genes by RT-PCR in catO cells. 
RT-PCR was performed using sybergreen for 3 independent experiments.  
 
We were not able to confirm the PCR-array results since the expression of Hey1, Timp3 and 
Thbs1 did not present any difference between controls and CatO cells. These results might 
be due to low efficiency of transfection. Therefore, we decided to perform 
immunofluorescence and in situ hybridization to analyze the effect of H2O2 decreased levels 
in the regulation of gene expression.  
 
 
3.1 Regulation of Notch signaling components by H2O2  
 
Because it was observed, in vivo, that overexpression of catalase in tumor cells led to less 
sprouting in the angiogenic process when compared to controls (Rodrigues, G., master thesis 
2011), we analyzed the expression of Notch signaling components.  Using in situ 
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hybridization in cell cultures transfected with control and catalase plasmid, we analyzed the 
expression of notch ligands Dll1, Dll4 and Jagged1, notch receptors, Notch 1 and Notch3 and 
the downstream targets Hey1, Hey2, Hes1, Hes4, Hes5 and Hes6. 
 
Of these, mRNA was only detected for Dll4, Notch3, Jagged1 and Hes1 (fig. 22).  
 
Fig. 23: In situ hybridization showing expression of ligands, receptors and effectors of the notch 
signaling pathway in 4T1 cell cultures.  mRNA in control and CatO cells was detected for Dll4, 
Jagg1, Notch3 and Hes1. Arrows indicate positive cells.   
 
To determine whether changes observed in the expression of Dll4, Jagged1, Notch3 and 
Hes1 are dependent on catalase overexpression, immunolabelling of catalase was performed 
after in situ hybridization (fig. 24). 
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Fig.  24: Catalase overexpression and mRNA expression for Dll4, Jagged1, Notch3 and Hes1 in 
4T1 cells. Catalase was detected by immunofluorescence (red) after in situ hybridization in 
4T1 catO cell. White arrows indicate in situ hybridization positive cells; black arrows indicate 
catO cells. 
 
The expression of Dll4, Notch3, Jagged1 and Hes1 occurs in cells with or without catalase 
overexpression. This result indicates that the overexpression of catalase is not able to 
regulate the expression of these genes.  
Differences in the overall number of cells expressing Dll4, Notch3, Jagged1 and Hes1 in 
control and CatO cell cultures could not be quantified as possible non-specific hybridization 
made cell counting an inaccurate method to determine variations. 
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3.2. Regulation of protein expression of antiangiogenic factors Bai1, Timp3 and Thbs1 by 
catalase overexpression  
To determine whether CatO cells (mCherry positive cells) presented differences in Timp3, 
Thbs1 and Bai1 expression levels comparing with untransfected cells (mCherry negative 
cells) we performed immunofluorescence assays. 
 
Fig. 25: Bai1 expression in HeLa and 4T1 cell cultures. Bai1 (green) was labelled with an 
antibody recognizing an extracellular peptide sequence and nuclei were stained with DAPI 
(blue).  
 
Bai1 protein was not detected in the 4T1 cell line by immunofluorescence (fig. 25) when 
compared to Hela cell line.  
 
The expression of Thbs1 occurred in both transfected and non-transfected cells and we 
concluded that no cell autonomous effect of catalase exists in Thbs1 expression (fig. 26).  
 
Fig. 26: Thbs 1 expression in control and catO 4T1 cells. Thbs1 (green), mCherry expression 
(red) indicates catalase transfected cells and nuclei were stained with DAPI (blue).  
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To evaluate whether an overall difference in Thbs1 expression existed between the two 
conditions, the number of Thbs1 positive cells in each experimental condition was counted 
and expressed as a percentage of the total number of cells for representative fields (fig 27).  
  
Fig. 27: Percentage of Thbs1 positive cells in control and catO 4T1 cell cultures, 24 hours after 
transfection (n=2) p=0,07.  
 
Although not significant due to the low number of independent experiments, catalase 
overexpression increased the percentage of cells expressing Thbs1 from approximately 6,7% 
to 11,1%. 
To test whether this effect was due to a decrease in H2O2 levels in the media we added 
10U/ml, 50U/ml and 100U/ml of extracellular catalase to untransfected 4T1 cells. 
 
 
Fig. 28: Thbs1 expression in 4T1 cell cultures incubated for 24 hours with 50U/ml (right) and 
100U/ml (left) of extracellular catalase. Thbs1 (green) was labelled with an antibody and nuclei 
were stained with DAPI (blue) (n=1). 
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A preliminary experiment with addition of extracellular catalase to cell media showed 
increase in number of cells with Thbs1 expression with 10U/ml of catalase similarly to 
catalase transfected cell cultures. This may mean that a decrease in extracellular H2O2 
upregulates Thbs1 expression. 
Paradoxically, increased amounts of extracellular catalase leads to a decrease in Thbs1 
expression. This might indicate that an excess in catalase expression might have a secondary 
effect on cell promoting Thbs1 downregulation. 
Further experiments are needed to confirm this result.  
In order to determine whether Thbs1 expression is also regulated by  a secreted factor 
present in the medium of catO cells we incubated untransfected cells with control or 
catalase transfected cell conditioned medium (CM). The number of Thbs1 positive cells in 
each experimental condition was counted and expressed as a percentage of the total 
number of cells for representative fields (fig 29). 
 
 
Fig. 29: Thbs1 expression in 4T1 cell cultures incubated with conditioned media from control 
and CatO cell cultures for 24 hours. Thbs1 expression (green) and nuclei were stained with 
DAPI (blue) (n=2)(p=0,19)  
 
Cells treated with CM from catalase transfected cells presented higher percentage of Thbs1 
positive cells (11,67%) than cells treated with CM from control cells (8,74%). 
Results 
 
   57 
 Although not significant (p=0,19), this result may indicate that CatO cells promote the 
production of a secreted factor that is able to regulate Thbs1 expression. 
 
In order to determine whether the regulation of Timp3 expression was also a non-
autonomous effect we tested whether extracellular regulated Timp3 expression (Fig. 30). 
 
Fig. 30: Timp3 expression in control and CatO 4T1 cells. Thbs1 expression (green), mCherry 
expression indicates catalase transfected cells (red) and nuclei were stained with DAPI (blue). 
  
Figure 30 shows an increase in Timp3 expression exclusively in catO cells. These results 
indicate that catalase regulates Timp3 expression in an autonomous manner.  
 
Fig 31:Timp3 expression in 4T1 cell cultures incubated for 24 hours with 10U/ml and 100U/ml 
of extracellular catalase. Timp3 (green) was labelled with an antibody and nuclei were stained 
with DAPI (blue). 
 
As shown in figure 31 extracellular catalase did not induce the expression of Timp3 
indicating that it is regulated by the expression of catalase cell autonomously. 
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4. CLONING OF PBRTOL-2-FLK1-KALTA4ERT2 FOR PRODUCTION OF A ZEBRAFISH TRANSGENIC LINE 
The pBRTol-2-flk1-KalTA4ERT2 will be used to obtain a Zebrafish transgenic line which 
expresses KalTA4ERT2 under the regulation of the endothelial specific flk1 promoter. 
KalTA4ERT2 is a fusion protein between a modified gal4 activating protein and estrogen 
receptor which translocates to the nucleus in presence of estrogen (Tamoxifen).  This 
construct is cloned into a Tol-2 transposon system for genome integration in Zebrafish to 
produce tg(flk1:KalTA4) line. This line will be crossed with tg(UAS:catalase). 
In presence of tamoxifen tg(flk1:KalTA4; UAS:catalase) will express catalase in a spatially and 
temporally controlled way.  
The cloning strategy described in Materials and methods section 9 results in plasmid pBRTol-
2 flk1-KalTA4-ERT2 with the structure below: 
 
Fig. 32: Predicted structure of the pBRTol-2 flk1-KalTA4-ERT2 plasmid. The final construct will 
contain the vector pBRTol-2 (4500bp), the flk1 promoter (6800bp) and the KalTA4 activator 
and ERT2 estrogen receptor fragment (3000bp). 
 
4.1 Screening of transformants 
An initial screening was done using DNA obtained from direct bacteria lysis (cracking 
method) (figure 33). Transformants with larger bands were chosen for further analysis. 
14300 bp 
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Fig. 33: Screening transformants for the pBRTol-2-flk1-KalTA4-ERT2 plasmid. DNA from 12 
transformants was extracted using the cracking method and ran on a 1% agarose gel. Samples 
with larger sized bands (lanes 2 and 10) were chosen. Generuler 1 Kb Plus was used as size 
ladder.  
 
Plasmid DNA from the chosen samples was extracted and analyzed via digestion with 
restriction enzymes.  
 
4.2 Confirmation of DNA fragments in putative pBRTol-2-flk1-KalTA4-ERT2 plasmid  
The plasmid was digested with XhoI, the same enzyme used for creating sticky ends for the 
pBR-Tol-2 vector and flk1 promoter and NcoI which has a unique site approximately 4300 bp 
downstream of the XhoI site. 
 
 
Fig.  34: Digestion of putative clone with XhoI and NcoI enzymes, yielding a fragment of flk1 
promoter. 
 
The band sizes obtained correspond to the expected ones. The plasmid will be sequenced to 
verify sequence accuracy prior to injection in Zebrafish oocytes.
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DISCUSSION 
 
H2O2 is involved in many aspects of cancer cell phenotype known to contribute to 
tumorigenesis, including the angiogenic process that enables tumor growth and 
dissemination.  
Catalase overexpression in both stable transfected cell lines and transgenic models have 
been shown to inhibit tumor angiogenesis and slow tumor progression (Glorieux, Dejeans et 
al. 2011), (Goh, Enns et al. 2011). However, in these studies catalase was homogeneously 
overexpressed in all cells and the effect of a small subset of cells overexpressing catalase was 
not addressed. 
Previous in vivo studies using the Zebrafish xenograft model have shown that lowering levels 
of H2O2 by catalase overexpression in a small percentage of 4T1 mouse breast tumor cells 
decreases tumor angiogenesis and vessel invasion significantly (Rodrigues, G., Ms thesis, 
2011). 
The mechanisms by which this overall effect is achieved by altering only a part of tumor cells 
are the object of this study. 
1. H2O2 REGULATES THE EXPRESSION OF ANGIOGENIC FACTORS  
By gene array analysis, we found changes affecting the expression of Notch effectors Hey1 
and Hey2 in catO cells indicating that H2O2-dependent regulation of angiogenesis could 
happen through the Notch signaling pathway. However, using in situ hybridization we could 
only verify the expression of the ligands Jagged1 and Dll4, the receptor Notch3 and the 
effector Hes1 in both control and catalase overexpressing cells while ligand Dll1, receptor 
Notch1 and effectors Hes4, Hes5, Hes6, Hey1 and Hey2 were not detected in 4T1 cells. 
In the same array analysis we identified Bai1, Ptn, Tdgf, Timp3 and Thbs1 as significantly 
overexpressed in catO cells. Of these we chose to study Bai1, Timp3 and Thbs1 since these 
factors function as angiogenesis inhibitors and can thus contribute to the phenotype 
observed in vivo. 
Further studies using in situ hybridization indicated that Jagged1, Dll4, Notch3 and Hes1 
expression is not regulated by catalase overexpression as the expression of these genes was 
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not concomitant with catalase overexpressing cells. However, more studies are needed to 
determine whether Notch signaling components could be regulated by H2O2 levels in a non-
autonomous way.  
Recently, Notch3 was found to be upregulated and required for tumor cell propagation on a 
subpopulation of non-small-cell-lung cancer with cancer stem cell properties (Zheng, 
de la Cruz et al. 2013) such as resistance to chemotherapy. 
As CSCs have been described as having low levels of ROS (Diehn, Cho et al. 2009), the 
relation between ROS, Notch expression and these tumor promoting cells may prove to be 
important for future therapeutic strategies. 
 
2. CELL AUTONOMOUS VS NON-AUTONOMOUS H2O2  EFFECT 
Bai1 expression was not detected by qRT-PCR or immunofluorescence, which was probably 
due to very low expression of this gene, forfeiting us the possibility of further studies. 
For Thbs1, a significant increase was found in number of Thbs1 positive cells in catalase 
overexpressing cell cultures when compared to controls. Yet the Thbs1 positive cells showed 
no correspondence with catalase overexpressing cells as observed using 
immunofluorescence, showing a non-autonomous effect.  
An increase, although not significant, was found in cells incubated with conditioned media 
from catalase overexpressing cells when compared with conditioned media from control 
cells. These results suggest that Thbs1 expression is controlled by extracellular factors 
induced by alterations in H2O2 levels in a small subpopulation of tumor cells. 
H2O2 reacts with and modulates the activity of several factors including signaling molecules 
and redox sensitive transcription factors, as previously described.  
We hypothesize that redox changes caused by catalase overexpressing affects the 
expression or activity of a secondary messenger responsible for Thbs1 induction. An increase 
in the expression or activity of such messenger would happen in conditioned media from 
catalase overexpressing cells.  
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Timp3 immunofluorescence, in contrast to Thbs1, showed an increase in Timp3 expression 
which is specific to catalase overexpressing cells. Assays with conditioned media and 
extracellular catalase were also performed and no Timp3 expression was observed in either 
case, confirming the cell autonomous effect of H2O2. 
H2O2 regulates expression at the transcription, translation and protein degradation levels but 
is also a key factor in signal transduction of extracellular factors.  
Timp3 regulation by H2O2 may occur at one or more of these levels. Timp3 downregulation 
has been linked to hypermethylation of its promoter in several cancers including invasive 
breast ductal cancer (Lui, E. L. H. et al 2005). In addition, Timp3 transcription is known to be 
induced by TGF-β and TNF-α signaling, and the downstream signaling of both these factors is 
modulated by H2O2 (Khokha, Murthy et al. 2013). The possibility that the increase in 
intracellular Timp3 is due to deficient exocytosis cannot be discarded and will be 
investigated in subsequent studies. 
The possible targets of H2O2 that have been found will need further confirmation.  
Of particular interest is the determination of overall expression changes in the notch 
pathway components in control and CatO populations, as it may have a non-autonomous 
effect. Determination of intermediates regulating Thbs1 and Timp3 expressing by analysis of 
changes in the conditioned media and inhibition of signal transduction component, 
respectively. 
The expression of these molecules should also be confirmed in an in vivo scenario which 
includes other determining factors in the tumor microenvironment, to understand their 
importance in the phenotype. 
The levels of endogenous H2O2 in endothelial cells are also a key factor in the angiogenic 
process. However, it is still unknown whether H2O2 regulates both physiological and 
pathological angiogenesis and in which stages of this process it could be determinant.  
To answer this questions we aim at creating a Zebrafish transgenic line that allows the 
inducible expression of catalase in endothelial cells by addition of the drug tamoxifen. This 
will allow the manipulation of H2O2 levels at different time points of the angiogenic process 
thus elucidating the different phases of this process.          
Conclusions  
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CONCLUSIONS  
 
The present work was aimed at identifying H2O2 regulated factors responsible for a decrease 
in tumor induced angiogenesis, observed when a subset of 4T1 tumor cells was transfected 
with a catalase overexpression plasmid in a Zebrafish xenograft model. 
Expression changes which may contribute to the observed phenotype were found in 
components of the Notch signaling pathway and molecules with antiangiogenic properties, 
namely Bai1, Thbs1 and Timp3. 
We observed that Dll4, Jagged1, Notch3 and Hes1 are expressed in 4T1, that this expression 
happened in both control and CatO cells and there was no apparent relation between the 
reduction of H2O2 levels and Notch pathway induction. 
We also found that the expression of Thbs1 and Timp3 was regulated by H2O2 in distinct 
ways: non-autonomously and autonomously. 
While Timp3 was upregulated specifically in cells overexpressing catalase, Thbs1 expression 
did not correlate in an autonomous way with catalase overexpression but presented a higher 
percentage of Thbs1 positive cells in CatO cell cultures and cells incubated with CatO cell 
culture conditioned media suggesting the role of a second messenger.  
Included in a broader study plan, this work also encompassed making a construct that will 
allow the creation of a Zebrafish transgenic expressing catalase in endothelial cells at specific 
times during angiogenesis by induction using tamoxifen. 
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To better understand the relevance and mechanisms of these angiogenic factors more 
assays are needed to confirm these results as well as new assays to characterize the way 
H2O2 performs this regulation 
Different pathways, such as MAPK and PI3K, may be inhibited to determine their 
involvement in the regulation process and other processes such as exocytosis of Timp3 may 
be analyzed. 
To understand whether the redox regulation uncovered in this study has in vivo relevance 
we will use the zebrafish tumor model optimized previously to analyze the expression of the 
H2O2-regulated proteins here identified.   
 
Supplementary materials 
 
   
SUPPLEMENTARY MATERIALS 
 
Table 16 
 
Angiogenesis related genes differently expressed in controls and catalase overexpressing 4T1 cells 
 
Symbol Function in angiogenesis 
Uniprot  
number 
References 
Bai1 
Brain-specific angiogenesis inhibitor 1 is a G-coupled protein receptor of the cell adhesion 
subfamily containing five thrombospondin type I repeats. Cleavage of its extracellular domain 
results in two molecules, vasculostatin 120 and vasculostatin 40, with strong antiangiogenic 
properties. 
Q3UHD1 Cork and Van Meir 2011 
Cga 
Glycoprotein hormones, alpha subunit is a subunit of several hormones involved in fetal 
angiogenesis. Its folding and secretion is dependent upon bonds between cysteine residues  
P01216 Tsampalas et al., 2010 
Chga 
Chromogranin A is a secretory protein used as a diagnostic serum marker for neuroendocrine 
tumors. The N-terminal fragment of Chromogranin A is the anti-angiogenic molecule Vasostatin I 
which reduces endothelial cell proliferation and migration.  
P26339 Belloni, Scabini et al. 2007 
Col4a3 
Collagen, type IV, alpha 3 has a proteolytic C-terminal non-collagenous (NC1) domain that is 
released by membrane degrading enzymes forming Tumstatin, an endogenous inhibitor of 
angiogenesis.  
Q9QZS0 
Boosani, C.S. and Sudhakar, A., 
2008 
Hey1 
Hairy/enhancer-of-split related with YRPW motif 1 is a Notch effector, involved in tip vs stalk cell 
selection and tumor and endothelial cell crosstalk 
Q9WV93 
Kofler, N.M. et al, 2011 
Hey2 
Hairy/enhancer-of-split related with YRPW motif 2 is a Notch effector, involved in tip vs stalk cell 
selection and tumor and endothelial cell crosstalk 
Q9QUS4 
IL12a 
Interleukin 12A and 12B form the Interleukin12 heterodimer that acts as angiogenesis inhibitor. 
However, this activity is mediated by regulating interferon γ and CXCL10 and expression levels of 
these were found to be unchanged. 
P43431 Angiolillo AL et al, 1996 
Ntrk2 
Neurotrophic tyrosine kinase, receptor, type 2 is involved in signal transduction cascades that 
regulate growth and survival and was associated with the expressions of VEGF, VEGF-C and 
VEGF-D 
P15209 (Sasahira, Ueda et al. 2013)  
Supplementary materials 
 
   
Prl7d1 
Prolactin family 7, subfamily d, member 1 is a hormone expressed mainly in the placenta and 
mammary gland involved in many cellular processes. Fragments of this hormone have been 
shown to have antiangiogenic activity. 
Q5SVM4 
Jackson et al, 1994 
Plg 
Plasminogen is a precursor to plasmin, a molecule that is reduced extracellularly and then 
cleaved to the potent angiogenesis inhibitor angiostatin 
P20918 
Gately S. et al 1997 
Stathakis P. et al 1999 
Ptn 
Pleiotrophin is a secreted heparin binding cytokine. It has strong pro-angiogenic effects through 
EC stimulation, signaling pathway activation and stromal alterations.  
P63089 
Perez-Pinera, Chang et al. 
2007 
Tdgf1 
Teratocarcinoma-derived growth factor 1 is an embryonic growth factor generally absent in 
adult tissues but known to be present in some tumors where it interacts with a variety of 
proteins in signaling pathways that drive tumorigenesis, including angiogenesis. 
P51865 
de Castro, Rangel et al. 2010 
Nagaoka, Karasawa et al. 2012 
Thbs1 
Thrombospondin 1 is a glycoprotein with multiple functional domains that can interact with 
constituents of the ECM, proteases and cell receptors. Its antitumorigenic and antiangiogenic 
properties have been thoroughly studied and established. 
P35441 
Tuszynski and Nicosia 1996 
Lawler and Lawler 2012 
Timp3 
Tissue inhibitor of metalloproteinase 3 is part of a family of endogenous antiangiogenic factors 
that act by inhibiting MMPs. Its binding to MMPs prevents ECM degradation and the release of 
proangiogenic molecules. It has also been shown to block VEGF binding to VEGFR2, 
independently of its timp function.  
P39876 
Apte, Olsen et al. 1995 
Qi, Ebrahem et al. 2003 
Timp4 
Tissue inhibitor of metalloproteinase 4 is also part of the family of endogenous antiangiogenic 
factors that inhibit MMPs. Similarly to Timp3, it binds to MMPs to prevent ECM degradation. 
Q9JHB3 Apte, Olsen et al. 1995 
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